false FY 0001822886 00-0000000

 HHGC:UnitsEachConsistingOfOneOrdinaryShareParValue0.0001PerShareOneRedeemableWarrantEntitlingHolderToPurchaseThreefourths34OfOrdinaryShareAndOneRightToAcquireOnetenthOfOrdinaryShareMember

 HHGC:OrdinarySharesMember

 HHGC:WarrantsMember

 us-gaap: RightsMember

 2024-03-28

 HHGC:PublicUnitsMember

 us-gaap: OverAllotmentOptionMember

 us-gaap: OverAllotmentOptionMember

 HHGC:PrivateUnitsMember

 2022-09-19
 2022-09-19

 2022-09-19

 2022-12-01
 2022-12-01

 2023-09-25
 2023-09-25

 2023-09-25

 HHGC:EquityInterestsMember

 HHGC:EquityInterestsMember

 HHGC:WaiverAgreementMember

 2022-08-16
 2022-08-17

 2022-09-18
 2022-09-19

 HHGC:AmericanStockTransferAndTrustCompanyMember
 HHGC:SeptemberTwentyThreeTwoThousandTwentyTwoToSeptemberTwentyThreeTwoThousandTwentyThreeMember

 2021-09-19

 2023-09-22
 2023-09-22

 HHGC:AmericanStockTransferAndTrustCompanyMember
 HHGC:SeptemberTwentyThreeThreeThousandTwentyTwoToSeptemberTwentyThreeTwoThousandTwentyFourMember

 2021-09-19

 2022-09-21

 2022-10-31

 2022-11-28

 2022-12-21

 2023-01-20

 2023-02-21

 2023-03-21

 2023-04-21

 2023-05-23

 2023-06-23

 2023-07-23

 2023-08-23

 2023-10-20

 2023-09-23

 2023-11-22

 2023-12-22

 2024-01-23

 2024-02-23

 2024-03-20

 HHGC:MergerAgreementMember
 HHGC:MergerConsiderationMember

 2023-08-02
 2023-08-02

 HHGC:MergerAgreementMember
 HHGC:MergerConsiderationMember

 2023-08-02

 HHGC:AmericanStockTransferAndTrustCompanyMember
 HHGC:SeptemberTwentyThreeThreeThousandTwentyTwoToSeptemberTwentyThreeTwoThousandTwentyFourMember

 HHGC:PerfectHexagonHoldingsLimitedMember

 HHGC:PerfectHexagonHoldingsLimitedMember

 HHGC:PerfectAcquisitionsLimitedMember

 HHGC:PerfectAcquisitionsLimitedMember

 us-gaap: FairValueInputsLevel1Member

 us-gaap: FairValueInputsLevel2Member

 us-gaap: FairValueInputsLevel3Member

 us-gaap: FairValueInputsLevel1Member

 us-gaap: FairValueInputsLevel2Member

 us-gaap: FairValueInputsLevel3Member

 HHGC:PublicSharesMember

 HHGC:PublicWarrantsAndPublicRightsMember

 HHGC:PublicUnitsMember

 HHGC:SponsorMember

 HHGC:SponsorMember

 HHGC:FounderMember

 2020-07-01
 2020-07-31

 HHGC:FounderMember

 2020-11-01
 2020-11-30

 HHGC:FounderMember

 2021-02-01
 2021-02-28

 HHGC:FounderMember

 2021-02-28

 2023-08-08

 2023-10-09

 2023-11-17

 HHGC:SponsorMember

 us-gaap: WarrantMember

 2022-09-20
 2022-09-21

 2022-09-21

 2023-09-20
 2023-09-21

 2023-09-21

 HHGC:UnderwritingAgreementMember

 HHGC:UnderwritingAgreementMember
 srt: MaximumMember

 HHGC:UnderwritingAgreementMember
 HHGC:InvestorsMember

 2024-02-09

 2024-03-22

 UNITED
STATES

 SECURITIES
AND EXCHANGE COMMISSION

 Washington,
D.C. 20549

 FORM

 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For
the fiscal year ended December 31, 2023

 or

 TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For
the transition period from _____________ to ________________

 Commission
file number: 001-40820

 HHG

 (Exact
name of registrant as specified in its charter)

 British
 Virgin Islands

 N/A

 (State
 or other jurisdiction of

 incorporation
 or organization)

 (I.R.S.
 Employer

 Identification
 No.)

 Commonwealth Lane

 #03-20,
 Singapore

 149544

 (Address
 of principal executive offices)

 (Zip
 Code)

 Registrant's
telephone number, including area code: +65 6659 1335

 Securities
registered pursuant to Section 12(b) of the Act:

 Title
 of each class

 Trading
 Symbol(s)

 Name
 of each exchange on which registered

 Units, each consisting of one Ordinary Share, par value $0.0001 per share, one Redeemable Warrant entitling the holder to purchase three-fourths
 (3/4) of an Ordinary Share, and one Right to acquire one-tenth of an Ordinary Share

 HHGCU

 Capital Market

 Shares

 HHGC

 Capital Market

 Warrants

 HHGCW

 Capital Market

 Rights

 HHGCR

 Capital Market

 Securities
registered pursuant to Section 12(g) of the Act: None.

by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No

by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes
 No

by check mark whether the registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days. Yes No

by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes No

by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer,"
"smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 Large
 accelerated filer

 Accelerated
 filer

 Non-accelerated
 filer

 Smaller
 reporting company

 Emerging
 Growth Company

 If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report.

 If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements.

by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b).

by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 At
June 30, 2023, the aggregate market value of the Registrant's ordinary shares held by non-affiliates of the Registrant was $ 2,529,764.

 As
of March 28, 2024, the Registrant had 5,050,561 ordinary shares outstanding.

 DOCUMENTS
INCORPORATED BY REFERENCE

 None.

 HHG

 Annual
Report on Form 10-K for the Year Ended December 31, 2023

 ITEM
 1.

 BUSINESS

 ITEM
 1A.

 RISK FACTORS

 ITEM
 1B.

 UNRESOLVED STAFF COMMENTS

 ITEM
 1C.

 CYBERSECURITY

 ITEM
 2.

 PROPERTIES

 ITEM
 3.

 LEGAL PROCEEDINGS

 ITEM
 4.

 MINE SAFETY DISCLOSURES

 ITEM
 5.

 MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 ITEM
 6.

 [RESERVED]

 ITEM
 7.

 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 ITEM
 7A.

 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 ITEM
 8.

 FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 ITEM
 9.

 CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 ITEM
 9A.

 CONTROLS AND PROCEDURES

 ITEM
 9B.

 OTHER INFORMATION

 ITEM
 9C.

 DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

 ITEM
 10.

 DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 ITEM
 11.

 EXECUTIVE COMPENSATION

 ITEM
 12.

 SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS

 ITEM
 13.

 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 ITEM
 14.

 PRINCIPAL ACCOUNTANT FEES AND SERVICES

 ITEM
 15.

 EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 ITEM
 16.

 FORM 10–K SUMMARY

 i

 Explanatory
Note

 General

 HHG
Capital Corporation ("HHGC," "Company," "we," "us," or "our, unless context dictates
otherwise) is filing this Annual Report on Form 10-K for the year ended December 31, 2023 (this "Report," "Form 10-K,"
or "Annual Report"). This Form 10-K contains our audited financial statements for the year ended December 31, 2023, as well
as restates certain financial information and related footnote disclosures in the Company's previously issued audited financial
statements for the fiscal year ended December 31, 2022 and unaudited interim financial statements included in the Company's Quarterly
Report on Form 10-Q for the quarterly periods ended March 31, 2023, June 30, 2023 and September 30, 2023, filed with the SEC on May 15,
2023, August 11, 2023 and November 14, 2023.

 Background
of Restatement

 During
the preparation of the Annual Report on Form 10-K for the year ended December 31, 2023, the Company management determined that it had
not appropriately accounted for interest earned on investments held in its Trust Account established in connection with the Company's
initial public offering for the benefit of the Company's public shareholders (the "Trust Account") under U.S. GAAP.
Interest income was recorded based on actual cash receipt instead of on an accrual basis, resulting in an understatement of Investments
held in Trust Account in prior periods. As a result, interest earned on investment held in Trust Account, net income, and ordinary shares
subject to redemption were misstated.

 In
accordance with Staff Accounting Bulletin ("SAB") 99, "Materiality", and SAB 108, "Considering the Effects
of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements", the Company's management
and the audit committee evaluated the materiality of the errors from qualitative and quantitative perspectives, individually and in aggregate,
and on March 20, 2024 concluded that the errors were material to the financial statements for the fiscal year ended December 31, 2022,
and the quarters ended March 31, 2023, June 30, 2023, and September 30, 2023 (collectively, the "Previously Issued Financial Statements")
and that the Previously Issued Financial Statements should no longer be relied upon and would require certain restatement adjustments.

 On
March 20, 2024, the Company's management and the audit committee of the Company's board of directors (the "Audit
Committee"), concluded that the Company's previously issued unaudited interim financial statements included in the Company's
Quarterly Report on Form 10-Q for the Affected Periods ("Original Quarterly Reports") should be restated and no longer be
relied upon due to misstatements in (i) investments held in Trust Account and Ordinary shares subject to
possible redemption on the Company's audited consolidated balance sheet as of December 31, 2022, and unaudited condensed consolidated
balance sheet as of March 31, 2023, June 30, 2023 and September 30, 2023 and (ii) change in classification of amount due to a related
party arising from unpaid administrative service fee on the Company's condensed statements of cash flows for the year ended December
31, 2022 and three months and six months ended March 31, 2023 and June 30, 2023. As such, the Company is restating the Company's
financial statements for the Affected Periods in this Form 10-K.

 The
restatement does not have an impact on the Company's cash position or amount held in the Trust Account.

 The
Previously Issued Financial Statements are superseded by the information in this Form 10-K. On March 20, 2024, the Company filed a Current
Report on Form 8-K disclosing the Company's management and the audit committee's conclusion that the Previously Issued Financial
Statements should no longer be relied upon.

 Internal
Control Considerations

 In
connection with the restatement, the Company's management has re-evaluated the effectiveness of the Company's disclosure
controls and procedures and internal control over financial reporting as of December 31, 2022, March 31, 2023, June 30, 2023, and September
30, 2023. The Company's management has concluded that, in light of the misstatement described above, and the restatements
of consolidated financial statements
as of and for the year ended December 31, 2022 and interim consolidated financial statement statements as of and for the periods ended
March 31, 2023, June 30, 2023, and September 30, 2023, a material weakness exists in the Company's internal control over
financial reporting and that the Company's disclosure controls and procedures were not effective. For a discussion of management's
consideration of our disclosure controls and procedures, internal controls over financial reporting, and the material weaknesses identified,
see Part II, Item 9A, "Controls and Procedures" of this Form 10-K.

 ii

 CERTAIN
TERMS

 References
to "the Company," "HHGC," "our," "us" or "we" refer to HHG Capital Corporation,
a blank check company incorporated in the British Virgin Islands on July 15, 2020. References to our "Sponsor" refer to Mr.
Hooy Kok Wai. References to our "IPO" or the "Initial Public Offering" refer to the initial public offering of
HHG Capital Corporation, which closed on September 23, 2021.

 SPECIAL
NOTE REGARDING FORWARD LOOKING STATEMENTS

 This
Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, or the
Securities Act, and Section 21E of the Securities Exchange Act of 1934, or the Exchange Act. The statements contained in this report
that are not purely historical are forward-looking statements. Our forward-looking statements include, but are not limited to, statements
regarding our or our management's expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any
statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying
assumptions, are forward-looking statements. The words "anticipates," "believe," "continue," "could,"
"estimate," "expect," "intend," "may," "might," "plan," "possible,"
"potential," "predict," "project," "should," "would" and similar expressions
may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking
statements in this report may include, for example, statements about our:

 ability
 to complete our initial business combination;

 success
 in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;

 officers
 and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving
 our initial business combination, as a result of which they would then receive expense reimbursements;

 potential
 ability to obtain additional financing to complete our initial business combination;

 pool
 of prospective target businesses;

 the
 ability of our officers and directors to generate a number of potential investment opportunities;

 potential
 change in control if we acquire one or more target businesses for stock;

 the
 potential liquidity and trading of our securities;

 the
 lack of a market for our securities;

 use
 of proceeds not held in the trust account or available to us from dividend on the trust account balance; or

 financial
 performance following our initial public offering.

 The
forward-looking statements contained in this report are based on our current expectations and beliefs concerning future developments
and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated.
These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions
that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.
These risks and uncertainties include, but are not limited to, those factors described under the heading "Risk Factors."
Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may
vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any
forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable
securities laws and/or if and when management knows or has a reasonable basis on which to conclude that previously disclosed projections
are no longer reasonably attainable.

 iii

 part
I

 ITEM
 1.

 BUSINESS

 Introduction

 HHG
Capital Corporation is a British Virgin Islands exempted company incorporated on July 15, 2020 as a blank check company for the purpose
of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business
combination, with one or more target businesses. Our efforts to identify a prospective target business will not be limited to any particular
industry or geographic location. However, we shall not undertake our initial business combination with any entity with its principal
business operations in China (including Hong Kong).

 We
believe that our management team is well positioned to identify attractive risk-adjusted returns in the marketplace and that our contacts
and transaction sources, ranging from industry executives, private owners, private equity funds, and investment bankers, in addition
to the geographical reach of our affiliates, will enable us to pursue a broad range of opportunities. Our management team has significant
experience in engaging in cross-border business in Asia, Europe, and the U.S., and understands the cultural, business and economic differences
and opportunities that will allow us to negotiate a transaction.

 On
September 23, 2021, the Company consummated the initial public offering of 5,750,000 units (the "Units"), which includes
the full exercise of the underwriter's over-allotment option of 750,000 Units. Each Unit consists of one ordinary share ("Ordinary
Share"), one redeemable warrant ("Warrant") entitling its holder to purchase three-fourths (3/4) of one Ordinary Share
at a price of $11.50 per whole share, and one right to receive one-tenth (1/10) of an Ordinary Share upon the consummation of an initial
business combination. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $57,500,000.

 On
September 23, 2021, simultaneously with the consummation of the IPO, we consummated the private placement ("Private Placement")
with Hooy Kok Wai, of 255,000 units (the "Private Units") at a price of $10.00 per Private Unit, generating total proceeds
of $2,550,000. The Private Units are identical to the Units sold in the IPO. Additionally, because the Private Units were issued in a
private transaction, the initial purchasers and their permitted transferees will be allowed to exercise the warrants included in the
Private Units for cash even if a registration statement covering the ordinary shares issuable upon exercise of such warrants is not effective
and receive unregistered ordinary shares. Additionally, such initial purchasers agreed not to transfer, assign or sell any of the Private
Units or underlying securities (except in limited circumstances, as described in the Registration Statement) until the completion of
the Company's initial business combination. Such Initial Purchasers were granted certain demand and piggyback registration rights
in connection with the purchase of the Private Units.

 A
total of $58,075,000 of the net proceeds from the sale of Units in the IPO (including the over-allotment option Units) and the private
placements on September 23, 2021 were placed in a trust account established for the benefit of the Company's public shareholders
at JPMorgan Chase Bank, N.A. maintained by American Stock Transfer & Trust Company, LLC, acting as trustee (the "Trust Account").
None of the funds held in trust will be released from the trust account, other than dividend to pay any tax obligations, until the earlier
of the completion of an initial business combination within the required time period or our entry into liquidation if we have not completed
a business combination in the required time period. On November 11, 2021, our ordinary shares, warrants and rights underlying the Units
sold in our IPO began to trade separately on a voluntary basis.

 On
August 2, 2023, we entered into an agreement and plan of merger (the "Merger Agreement") with Perfect Hexagon Holdings Limited,
a British Virgin Islands business company and wholly owned subsidiary of the Parent ("Purchaser"), Perfect Acquisitions Limited,
a British Virgin Islands business company and wholly owned subsidiary of Purchaser ("Merger Sub"), and Perfect Hexagon Group
Limited, a British Virgin Islands business company ( "PHGL"). Upon the closing of the transactions contemplated by the Merger
Agreement, (a) HHGC will be merged with and into Purchaser (the "Reincorporation Merger"), with Purchaser surviving the Reincorporation
Merger, and (b) Merger Sub will be merged with and into PHGL(the "Acquisition Merger"), with PHGL surviving the Acquisition
Merger as a direct wholly owned subsidiary of Purchaser (collectively, the "Merger" or the "Business Combination").
Following the Business Combination, Purchaser will be a publicly traded company listed on a stock exchange in the United States.

to the terms of the Merger Agreement, the aggregate consideration to be paid at the closing of the Business Combination to existing shareholders
of PHGL is $990,000,000 (the "Merger Consideration"), which will be paid in 99,000,000 newly issued ordinary shares of the
Purchaser at a deemed price of $10.00 per share.

 Extensions
of Time Period to Complete a Business Combination

 On
September 19, 2022, the shareholders of the Company approved the third amended and restated memorandum and articles of association (the
"Charter Amendment"), giving the Company the right to extend the date by which it has to complete a business combination
(the "Business Combination Period") up to twelve (12) times for an additional one (1) month each time, from September 23,
2022 up to September 23, 2023. Additionally, the Charter Amendment also allowed the holders of the ordinary shares issued in the IPO
(the "Public Shares") to redeem the shares when the Directors of the Company propose any amendment to the Company's
amended and restated memorandum and article of association that would affect the substance or timing of the redemption of the Public
Shares. Accordingly, on September 19, 2022, 2,393,594 Public Shares were redeemed for the pro-rata share of the deposits then in the
Trust Account, amounting to $24,274,780. The Company has extended the Business Combination Period on September 21, 2022, October 31,
2022, November 28, 2022, December 21, 2022, January 20, 2023, February 21, 2023, March 21, 2023, April 21, 2023, May 22, 2023, June 23,
2023, July 23, 2023, and August 22, 2023, by depositing into the Trust Account $9,080.20 for each one-month extension in order to extend
the amount of time it has available to complete a business combination,

 In
connection with the Charter Amendment, on August 18, 2022, HHGC entered into an agreement (the "Waiver Agreement") with Mr.
Hooy Kok Wai (the "Sponsor") and certain other holders of Public Shares (these shareholders, together with the Sponsor, the
"Anchor Shareholders") and who, as of date of this filing, together own 3,084,000 Public Shares, which represent 61.06% of all
outstanding Ordinary Shares that are owned by our public shareholders (the "Waiver Shares"). Pursuant to the Waiver Agreement,
the Anchor Shareholders have agreed to waive their pro rata share of all Extension Payments made into the Trust Account that otherwise
would be payable on their Waiver Shares commencing the date of the Waiver Agreement. As a result, each Extension Payment that would be paid
into the Trust Account after August 18, 2022 is to be segregated so that only HHGC's public shareholders who have not redeemed
their ordinary shares, excluding the Anchor Shareholders, would receive their pro rata share of each such monthly extension payment (in
addition to their pro rata share of amounts then in the Trust Account) upon redemption or upon the liquidation of HHGC. The Waiver Agreement
also provides that the Anchor Shareholders will agree not to sell or otherwise transfer any of their Waiver Shares (subject to customary
exceptions for transfers to certain family members and other affiliates) other than in connection with a redemption of their Waiver Shares
or in the event that HHGC is forced to dissolve or liquidate. The Waiver Agreement will result in no economic change to the existing
rights of all other public shareholders (i.e., those shareholders holding non-waiving Public Shares) in and to their pro rata share of
the Trust Fund, all of whom will continue to accrue the same $0.0333 per share for each one month. Non-waiving Public Shares are the shares held by the shareholders holding public shares but did not enter the
Waiver Agreement and are entitled to receive the monthly Extension Payments which the Company deposits into the Trust Fund.

 As
approved by its shareholders at the annual meeting of Shareholders held on September 21, 2023, HHGC entered into an amendment to the
investment management trust agreement, dated as of September 22, 2023, with Equiniti Trust Company LLC (formerly known as American Stock
Transfer & Trust Company) and filed a fourth amended and restated memorandum and articles of association on September 21, 2023, giving
HHGC the right to extend the time to complete a business combination twelve (12) times for a total of up to 36 months after the consummation
of the IPO, by depositing into the Trust Account $0.0333 for each issued and outstanding Public Share, other than the Waiver Shares,
that has not been redeemed. On each of September 22, 2023, October 20, 2023, November 22, 2023, December 22, 2023, January 23, 2024,
 February 23, 2024 and March 22, 2024. HHGC deposited the amount of $7,985.40 into the Trust Account to extend the available time to complete
a business combination for an additional one month.

 Competitive
strengths

 Our
management team is led by Mr. Chee Shiong (Keith) Kok who has over two decades of combined operational, deal-making and commercial experience.
Our mission is to unlock value for our shareholders by identifying an acquisition target in any sector with potential to grow. Given
the diversified experience of our management team, we believe we have significant resources to identify, diligence, and structure transactions
that would benefit all shareholders. We could also get deal sources from our Sponsor, or affiliates of our Sponsor. Our competitive strengths
include the following:

 Deep
Experience of Operating Partners

 We
believe that our ability to leverage the experience of the management team, which comprises executives of different companies across
multiple sectors and industries, will provide us a distinct advantage in being able to source, evaluate and consummate an attractive
transaction.

 Proprietary
Sourcing Channels and Leading Industry Relationships

 We
believe the capabilities and connections associated with our management team, in combination with our Sponsor and our strategic and operating
partners, will provide us with a differentiated pipeline of acquisition opportunities. We expect these sourcing capabilities will be
further bolstered by our reputation and deep industry relationships.

 Track
Record of Investment Experience

 We
believe that our management's track record of identifying and sourcing transactions positions us well to appropriately evaluate
potential business combinations and select one that will be well received by the public markets.

 Execution
and Deal Structuring Capability

 Our
combined expertise and reputation will allow us to source and complete transactions possessing structural attributes that create an attractive
investment thesis. These types of transactions are typically complex and require creativity, industry knowledge and expertise, rigorous
due diligence, and extensive negotiations and documentation. We believe that by focusing our investment activities on these types of
transactions, we are able to generate investment opportunities that have attractive risk/reward profiles based on their valuations and
structural characteristics.

 Status
as a Publicly Listed Company

 We
believe our structure will make us an attractive business combination partner to prospective target businesses. As a publicly listed
company, we will offer a target business an alternative to the traditional initial public offering. We believe that target businesses
will favor this alternative, which we believe is less expensive, while offering greater certainty of execution than the traditional initial
public offering. During an initial public offering, there are typically expenses incurred in marketing, which would be costlier than
a business combination with us. Furthermore, once a proposed business combination is approved by our shareholders (if applicable) and
the transaction is consummated, the target business will have effectively become public, whereas an initial public offering is always
subject to the underwriters' ability to complete the offering, as well as general market conditions that could prevent the offering
from occurring. Once public, we believe the target business would have greater access to capital and additional means of creating management
incentives that are better aligned with shareholders' interests than it would as a private company. It can offer further benefits
by augmenting a company's profile among potential new customers and vendors and aid in attracting talented management staffs.

 Competitive
Weaknesses

 We
believe our competitive weaknesses to be the following:

 Limited
Financial Resources

 Our
financial reserves will be relatively limited when contrasted with those of venture capital firms, leveraged buyout firms and operating
businesses competing for acquisitions. In addition, our financial resources could be reduced because of our obligation to redeem shares
held by our public shareholders as well as any tender offer we conduct.

 Lack
of experience with blank check companies

 Our
management team is not experienced in pursuing business combinations on behalf of blank check companies. Other blank check companies
may be sponsored and managed by individuals with prior experience in completing business combinations between blank check companies and
target businesses. Our managements' lack of experience may not be viewed favorably by target businesses.

 Limited
technical and human resources

 As
a blank check company, we have limited technical and human resources. Many venture capital funds, leveraged buyout firms and operating
businesses possess greater technical and human resources than we do and thus we may be at a disadvantage when competing with them for
target businesses.

 Delay
associated with shareholder approval or tender offer

 We
may be required to seek shareholder approval of our initial business combination. If we are not required to obtain shareholder approval
of an initial business combination, we will allow our shareholders to sell their shares to us pursuant to a tender offer. Both seeking
shareholder approval and conducting a tender offer will delay the consummation of our initial business combination. Other companies competing
with us for acquisition opportunities may not be subject to similar requirement, or may be able to satisfy such requirements more quickly
than we can. As a result, we may be at a disadvantage in competing for these opportunities.

 Effecting
an Acquisition Transaction

 General

 We
are not presently engaged in, and we will not engage in, any substantive commercial business until we complete a business combination.
We intend to utilize cash derived from the proceeds of the IPO and the Private Placements, our capital stock, debt or a combination of
these in effecting our initial business combination. Although substantially all of the net proceeds of the IPO and the Private Placements
are intended to be applied generally toward effecting a business combination, the proceeds are not otherwise being designated for any
more specific purposes. Accordingly, investors in the IPO were investing without first having an opportunity to evaluate the specific
merits or risks of any one or more business combinations. Our initial business combination may involve the acquisition of, or merger
with, a company which does not need substantial additional capital but which desires to establish a public trading market for its shares.
In the alternative, we may seek to consummate a business combination with a company that may be in its early stages of development or
growth. While we may seek to effect simultaneous business combinations with more than one target business, we will probably have the
ability, as a result of our limited resources, to effect only a single business combination.

 Sources
of Target Businesses

 We
believe based on our management's business knowledge and past experience that there are numerous business combination candidates.
We anticipate that target business candidates will be brought to our attention from various unaffiliated sources, including investment
bankers, venture capital funds, private equity funds, leveraged buyout funds, management buyout funds and other members of the financial
community. Target businesses may be brought to our attention by such unaffiliated sources as a result of being solicited by us through
calls or mailings. These sources may also introduce us to target businesses in which they think we may be interested in an unsolicited
basis, since many of these sources will have known what types of businesses we are targeting. Our officers and directors, as well as
their affiliates, may also bring to our attention target business candidates that they become aware of through their business contacts
as a result of formal or informal inquiries or discussions they may have, as well as attending trade shows or conventions. We may engage
professional firms or other individuals that specialize in business acquisitions or mergers in the future, in which event we may pay
a finder's fee, consulting fee or other compensation to be determined in an arm's length negotiation based on the terms of
the transaction. In no event, however, will our insiders or any of the members of our management team be paid any finder's fee,
consulting fee or other compensation prior to, or for any services they render in order to effectuate, the consummation of our initial
business combination (regardless of the type of transaction that it is). If we decide to enter into a business combination with a target
business that is affiliated with our officers, directors or initial shareholders, we will do so only if we have obtained an opinion from
an independent investment banking firm that the business combination is fair to our unaffiliated shareholders from a financial point
of view. As of the date of this report, there are no affiliated entities that we would consider as a business combination target.

 Selection
of a Target Business and Structuring of Our Initial Business Combination

 Subject
to our management team's fiduciary duties and the limitation that one or more target businesses have an aggregate fair market value
of at least 80% of the balance in the trust account (excluding any deferred underwriter's fees and taxes payable on the income
earned on the trust account) at the time of the execution of a definitive agreement for our initial business combination, as described
below in more detail, our management will have virtually unrestricted flexibility in identifying and selecting a prospective target business.
Additionally, there is no limitation on our ability to raise funds privately or through loans in connection with our initial business
combination. We have not established any specific attributes or criteria (financial or otherwise) for prospective target businesses.

 Accordingly,
there is no basis for investors to evaluate the possible merits or risks of the target business with which we may ultimately complete
a business combination. To the extent we effect our initial business combination with an entity in its early stage of development or
growth, including entities without established records of sales or earnings, we may be affected by numerous risks inherent in the business
and operations of early stage or potential emerging growth companies. Although our management will endeavor to evaluate the risks inherent
in a particular target business, we may not properly ascertain or assess all significant risk factors. In evaluating a prospective target
business, our management may consider a variety of factors, including one or more of the following:

 financial
 condition and results of operation;

 growth
 potential;

 experience
 and skill of management and availability of additional personnel;

 capital
 requirements;

 competitive
 position;

 barriers
 to entry;

 stage
 of development of the products, processes or services;

 degree
 of current or potential market acceptance of the products, processes or services;

 proprietary
 aspects of products and the extent of intellectual property or other protection for products or formulas;

 regulatory
 environment of the industry; and

 costs
 associated with effecting the business combination.

 These
criteria are not intended to be exhaustive. Our management may not consider any of the above criteria in evaluating a prospective target
business. The retention of our officers and directors following the completion of any business combination will not be a material consideration
in our evaluation of a prospective target business.

 Any
evaluation relating to the merits of a particular business combination will be based, to the extent relevant, on the above factors as
well as other considerations deemed relevant by our management in effecting a business combination consistent with our business objective.
In evaluating a prospective target business, we will conduct an extensive due diligence review which will encompass, among other things,
meetings with incumbent management and inspection of facilities, as well as review of financial and other information which is made available
to us. This due diligence review will be conducted either by our management or by unaffiliated third parties we may engage, although
we have no current intention to engage any such third parties.

 The
time and costs required to select and evaluate a target business and to structure and complete our initial business combination remain
to be determined. Any costs incurred with respect to the identification and evaluation of a prospective target business with which a
business combination is not ultimately completed will result in a loss to us and reduce the amount of capital available to otherwise
complete a business combination.

 Fair
Market Value of Target Business

to Nasdaq listing rules, our initial business combination must occur with one or more target businesses having an aggregate fair market
value equal to at least 80% of the balance of the funds in the trust account (excluding any deferred underwriter's fees and taxes
payable on the income earned on the trust account), which we refer to as the 80% test, at the time of the execution of a definitive agreement
for our initial business combination, although we may structure a business combination with one or more target businesses whose fair
market value significantly exceeds 80% of the trust account balance. If we are no longer listed on Nasdaq, we will not be required to
satisfy the 80% test.

 We
currently anticipate structuring a business combination to acquire 100% of the equity interests or assets of the target business or businesses.
We may, however, structure a business combination where we merge directly with the target business or where we acquire less than 100%
of such interests or assets of the target business in order to meet certain objectives of the target management team or shareholders
or for other reasons, but we will only complete such business combination if the post-transaction company owns 50% or more of the outstanding
voting securities of the target or otherwise owns a controlling interest in the target sufficient for it not to be required to register
as an investment company under the Investment Company Act. Even if the post-transaction company owns 50% or more of the voting securities
of the target, our shareholders prior to the business combination may collectively own a minority interest in the post-transaction company,
depending on valuations ascribed to the target and us in the business combination transaction. For example, we could pursue a transaction
in which we issue a substantial number of new shares in exchange for all of the outstanding capital stock of a target. In this case,
we would acquire a 100% controlling interest in the target. However, as a result of the issuance of a substantial number of new shares,
our shareholders immediately prior to our initial business combination could own less than a majority of our outstanding shares subsequent
to our initial business combination. If less than 100% of the equity interests or assets of a target business or businesses are owned
or acquired by the post-transaction company, the portion of such business or businesses that is owned or acquired is what will be valued
for purposes of the 80% test. In order to consummate such an acquisition, we may issue a significant amount of our debt or equity securities
to the sellers of such businesses and/or seek to raise additional funds through a private offering of debt or equity securities. The
fair market value of the target will be determined by our board of directors based upon one or more standards generally accepted by the
financial community (such as actual and potential sales, earnings, cash flow and/or book value). If our board is not able to independently
determine that the target business has a sufficient fair market value, we will obtain an opinion from an unaffiliated, independent investment
banking firm, or another independent entity that commonly renders valuation opinions on the type of target business we are seeking to
acquire, with respect to the satisfaction of such criteria. We will not be required to obtain an opinion from an independent investment
banking firm, or another independent entity that commonly renders valuation opinions on the type of target business we are seeking to
acquire ("Valuation Firms"), as to the fair market value if our board of directors independently determines that the target
business complies with the 80% threshold. However, if we seek to consummate an initial business combination with an entity that is affiliated
with any of our officers, directors or insiders and are therefore required to obtain an opinion from an independent investment banking
firm that the business combination is fair to our unaffiliated shareholders from a financial point of view, we may ask that a Valuation
Firm to opine on whether the target business met the 80% fair market value test. Nevertheless, we are not required to do so and could
determine not to do so without consent of our shareholders.

 Lack
of Business Diversification

 Our
business combination must be with a target business or businesses that collectively satisfy the minimum valuation standard at the time
of such acquisition, as discussed above, although this process may entail the simultaneous acquisitions of several operating businesses.
Therefore, at least initially, the prospects for our success may be entirely dependent upon the future performance of a single business
operation. Unlike other entities which may have the resources to complete several business combinations of entities operating in multiple
industries or multiple areas of a single industry, it is probable that we will not have the resources to diversify our operations or
benefit from the possible spreading of risks or offsetting of losses. By consummating our initial business combination with only a single
entity, our lack of diversification may:

 subject
 us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact upon
 the particular industry in which we may operate subsequent to our initial business combination, and

 result
 in our dependency upon the performance of a single operating business or the development or market acceptance of a single or limited
 number of products, processes or services.

 If
we determine to simultaneously consummate our initial business combination with several businesses and such businesses are owned by different
sellers, we will need for each of such sellers to agree that our purchase of its business is contingent on the simultaneous closings
of the other combinations, which may make it more difficult for us, and delay our ability, to complete the business combination. With
a business combination with several businesses, we could also face additional risks, including additional burdens and costs with respect
to possible multiple negotiations and due diligence investigations and the additional risks associated with the subsequent assimilation
of the operations and services or products of the target companies in a single operating business.

 Limited
Ability to Evaluate the Target Business' Management Team

 Although
we intend to scrutinize the management team of a prospective target business when evaluating the desirability of effecting our initial
business combination, our assessment of the target business' management team may not prove to be correct. In addition, the future
management team may not have the necessary skills, qualifications or abilities to manage a public company. Furthermore, the future role
of our officers and directors, if any, in the target business following our initial business combination remains to be determined. While
it is possible that some of our key personnel will remain associated in senior management or advisory positions with us following our
initial business combination, it is unlikely that they will devote their full time efforts to our affairs subsequent to our initial business
combination. Moreover, they would only be able to remain with the company after the consummation of our initial business combination
if they are able to negotiate employment or consulting agreements in connection with the business combination. Such negotiations would
take place simultaneously with the negotiation of the business combination and could provide for them to receive compensation in the
form of cash payments and/or our securities for services they would render to the company after the consummation of the business combination.
While the personal and financial interests of our key personnel may influence their motivation in identifying and selecting a target
business, their ability to remain with the company after the consummation of our initial business combination will not be the determining
factor in our decision as to whether or not we will proceed with any potential business combination. Additionally, our officers and directors
may not have significant experience or knowledge relating to the operations of the particular target business.

 Following
our initial business combination, we may seek to recruit additional managers to supplement the incumbent management of the target business.
We may not have the ability to recruit additional managers, or that any such additional managers we do recruit will have the requisite
skills, knowledge or experience necessary to enhance the incumbent management.

 Shareholder
Approval of Business Combination

 In
connection with any proposed business combination, we will either (1) seek shareholder approval of our initial business combination at
a meeting called for such purpose at which public shareholders may seek to redeem their public shares, regardless of whether they vote
for or against the proposed business combination, into their pro rata share of the aggregate amount then on deposit in the trust account
(net of taxes payable) or (2) provide our public shareholders with the opportunity to sell their public shares to us by means of a tender
offer (and thereby avoid the need for a shareholder vote) for an amount equal to their pro rata share of the aggregate amount then on
deposit in the trust account (net of taxes payable), in each case subject to the limitations described herein. Notwithstanding the foregoing,
our initial shareholders have agreed, pursuant to written letter agreements with us, not to redeem any public shares held by them into
their pro rata share of the aggregate amount then on deposit in the trust account. If we determine to engage in a tender offer, such
tender offer will be structured so that each shareholder may tender any or all of his, her or its public shares rather than some pro
rata portion of his, her or its shares. The decision as to whether we will seek shareholder approval of a proposed business combination
or will allow shareholders to sell their shares to us in a tender offer will be made by us based on a variety of factors such as the
timing of the transaction, whether the terms of the transaction would otherwise require us to seek shareholder approval or whether we
were deemed to be a foreign private issuer (which would require us to conduct a tender offer rather than seeking shareholder approval
under SEC rules). If we so choose and we are legally permitted to do so, we have the flexibility to avoid a shareholder vote and allow
our shareholders to sell their shares pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act which regulate issuer tender offers.
In that case, we will file tender offer documents with the SEC which will contain substantially the same financial and other information
about the initial business combination as is required under the SEC's proxy rules. We will consummate our initial business combination
only if we have net tangible assets of at least $5,000,001 upon such consummation and, solely if we seek shareholder approval, a majority
of the issued and outstanding ordinary shares voted are voted in favor of the business combination.

 We
chose our net tangible asset threshold of $5,000,001 to ensure that we would avoid being subject to Rule 419 promulgated under the Securities
Act. However, if we seek to consummate an initial business combination with a target business that imposes any type of working capital
closing condition or requires us to have a minimum amount of funds available from the trust account upon consummation of such initial
business combination, our net tangible asset threshold may limit our ability to consummate such initial business combination (as we may
be required to have a lesser number of shares redeemed or sold to us) and may force us to seek third party financing which may not be
available on terms acceptable to us or at all. As a result, we may not be able to consummate such initial business combination and we
may not be able to locate another suitable target within the applicable time period, if at all.

 Our
initial shareholders and our officers and directors have agreed (1) to vote any ordinary shares owned by them in favor of any proposed
business combination, (2) not to redeem any ordinary shares in connection with a shareholder vote to approve a proposed initial business
combination and (3) not sell any ordinary shares in any tender in connection with a proposed initial business combination.

 None
of our officers, directors, initial shareholders or their affiliates has indicated any intention to purchase Units or Ordinary Shares
from persons in the open market or in private transactions (other than the Private Units). However, if we hold a meeting to approve a
proposed business combination and a significant number of shareholders vote, or indicate an intention to vote, against such proposed
business combination, our officers, directors, initial shareholders or their affiliates could make such purchases in the open market
or in private transactions in order to influence the vote. Notwithstanding the foregoing, our officers, directors, initial shareholders
and their affiliates will not make purchases of Ordinary Shares if the purchases would violate Section 9(a)(2) or Rule 10b-5 of the Exchange
Act, which are rules designed to stop potential manipulation of a company's stock.

 Conversion
/Tender Rights

 At
any meeting called to approve an initial business combination, public shareholders may seek to convert their public shares, regardless
of whether they vote for or against the proposed business combination, into their pro rata share of the aggregate amount then on deposit
in the trust account, less any taxes then due but not yet paid. Notwithstanding the foregoing, our initial shareholders have agreed,
pursuant to written letter agreements with us, not to convert any public shares held by them into their pro rata share of the aggregate
amount then on deposit in the trust account. The redemption rights will be effected under our third amended and restated memorandum and
articles of association and British Virgin Islands law as redemptions. If we hold a meeting to approve an initial business combination,
a holder will always have the ability to vote against a proposed business combination and not seek conversion of his shares.

 Alternatively,
if we engage in a tender offer, each public shareholder will be provided the opportunity to sell his public shares to us in such tender
offer. The tender offer rules require us to hold the tender offer open for at least 20 business days. Accordingly, this is the minimum
amount of time we would need to provide holders to determine whether they want to sell their public shares to us in the tender offer
or remain an investor in our company.

 Our
initial shareholders, officers and directors will not have redemption rights with respect to any ordinary shares owned by them, directly
or indirectly, whether acquired prior to the IPO, in the IPO or in the aftermarket.

 We
may also require public shareholders, whether they are a record holder or hold their shares in "street name," to either tender
their certificates (if any) to our transfer agent or to deliver their shares to the transfer agent electronically using Depository Trust
Company's DWAC (Deposit/Withdrawal At Custodian) System, at the holder's option, at any time at or prior to the vote on the
business combination. Once the shares are converted by the holder, and effectively redeemed by us under British Virgin Islands law, the
transfer agent will then update our Register of Members to reflect all conversions The proxy solicitation materials that we will furnish
to shareholders in connection with the vote for any proposed business combination will indicate whether we are requiring shareholders
to satisfy such delivery requirements. Accordingly, a shareholder would have from the time our proxy statement is mailed through the
vote on the business combination to deliver his shares if he wishes to seek to exercise his redemption rights. Under our third amended
and restated memorandum and articles of association, we are required to provide at least 10 days' advance notice of any shareholder
meeting, which would be the minimum amount of time a shareholder would have to determine whether to exercise redemption rights. As a
result, if we require public shareholders who wish to convert their ordinary shares into the right to receive a pro rata portion of the
funds in the trust account to comply with the foregoing delivery requirements, holders may not have sufficient time to receive the notice
and deliver their shares for conversion. Accordingly, investors may not be able to exercise their redemption rights and may be forced
to retain our securities when they otherwise would not want to.

 There
is a nominal cost associated with this tendering process and the act of certificating the shares or delivering them through the DWAC
System. The transfer agent will typically charge the tendering broker $45 and it would be up to the broker whether or not to pass this
cost on to the converting holder. However, this fee would be incurred regardless of whether or not we require holders seeking to exercise
redemption rights. The need to deliver shares is a requirement of exercising redemption rights regardless of the timing of when such
delivery must be effectuated. However, in the event we require shareholders seeking to exercise redemption rights to deliver their shares
prior to the consummation of the proposed business combination and the proposed business combination is not consummated, this may result
in an increased cost to shareholders.

 Any
request to convert or tender such shares once made, may be withdrawn at any time up to the vote on the proposed business combination
or expiration of the tender offer. Furthermore, if a holder of a public share delivered his certificate in connection with an election
of their conversion or tender and subsequently decides prior to the vote on the business combination or the expiration of the tender
offer not to elect to exercise such rights, he may simply request that the transfer agent return the certificate (physically or electronically).

 If
the initial business combination is not approved or completed for any reason, then our public shareholders who elected to exercise their
conversion or tender rights would not be entitled to convert their shares for the applicable pro rata share of the trust account. In
such case, we will promptly return any shares delivered by public holders.

 Automatic
Liquidation if No Business Combination

 If
we do not complete a business combination by September 23, 2024 (assuming full extension), it will trigger our automatic winding up,
dissolution and liquidation pursuant to the terms of our third amended and restated memorandum and articles of association. As a
result, this has the same effect as if we had formally gone through a voluntary liquidation procedure under the Companies Act.
Accordingly, no vote would be required from our shareholders to commence such a voluntary winding up, dissolution and liquidation.
Pursuant to the terms of our third amended and restated memorandum and articles of association and the amended trust agreement
entered into between us and Equiniti Trust Company LLC (formerly known as American Stock Transfer & Trust Company) on September
22, 2023 the Company has the right to extend the time to complete a business combination twelve (12) times for an additional one (1)
month each time from September 23, 2023, to September 23, 2024, by depositing $0.0333 for each issued and outstanding
Company's ordinary share issued in the IPO that has not been redeemed held by shareholders who did not enter into the Waiver
Agreement (each, a "non-waiving Public Share") (or an aggregate of $9,080.20 if there are no redemptions) for each
one-month extension. Non-waiving Public Shares are the shares held by the shareholders holding public shares but did not enter the
"Waiver Agreement" and are entitled to receive the monthly Extension Payments which the Company deposits into the Trust
Fund. In the event the balance of the funds in the Company's operating account, excluding Trust Account minimum requirement,
falls below $100,000, the insiders will contribute to the Company as a loan for extension payment upon five (5) days' advance
notice prior to the applicable deadlines. The insiders will receive a non-interest bearing, unsecured promissory note equal to the
amount of any such deposit made by the insiders that will not be repaid in the event that we are unable to close a business
combination unless there are funds available outside the trust account to do so. Such notes would either be paid upon consummation
of our initial business combination, or, at the lender's discretion, converted upon consummation of our business combination
into additional private units at a price of $10.00 per unit. Our shareholders have approved the issuance of the private units upon
conversion of such notes, to the extent the holder wishes to so convert such notes at the time of the consummation of our initial
business combination. In the event that we receive notice from our insiders five days prior to the applicable deadline of their
intent to effect an extension, we intend to issue a press release announcing the deposit of funds promptly after such funds are
deposited into the trust account. Our insiders and their affiliates or designees are not obligated to fund the trust account to
extend the time for us to complete our initial business combination. To the extent that some, but not all, of our insiders, decide
to extend the period of time to consummate our initial business combination, such insiders (or their affiliates or designees) may
deposit the entire amount required. If we are unable to consummate our initial business combination within such time period, we
will, as promptly as possible but not more than ten business days thereafter, redeem 100% of our outstanding public shares for a pro
rata portion of the funds held in the trust account, including a pro rata portion of any dividend earned on the funds held in the
trust account and not necessary to pay our taxes, and then seek to liquidate and dissolve. However, we may not be able to distribute
such amounts as a result of claims of creditors which may take priority over the claims of our public shareholders. In the event of
our dissolution and liquidation, the public rights will expire and will be worthless.

 Except as set forth below, the proceeds in the trust account will not be
released until the earlier of the completion of an initial business combination within the required time period or our entry into liquidation
if we have not completed a business combination in the required time period. Therefore, unless and until an initial business combination
is consummated, the proceeds held in the trust account will not be available for our use for any expenses which we may incur related to
the investigation and selection of a target business and the negotiation of an agreement to acquire a target business. Notwithstanding
the foregoing, there will be released to us from the trust account any interest earned on the funds in the trust account that we need
to pay our income or other tax obligations. If we are forced to liquidate the trust account, we anticipate that we would distribute to our public shareholders the amount
in the trust account calculated as of the date that is two days prior to the distribution date (including any accrued interest). Prior
to such distribution, we would be required to assess all claims that may be potentially brought against us by our creditors for amounts
they are actually owed and make provision for such amounts, as creditors take priority over our public shareholders with respect to amounts
that are owed to them. We cannot assure you that we will properly assess all claims that may be potentially brought against us. As such,
our shareholders could potentially be liable for any claims of creditors to the extent of distributions received by them as an unlawful
payment in the event we enter an insolvent liquidation. Furthermore, while we will seek to have all vendors and service providers (which
would include any third parties we engaged to assist us in any way in connection with our search for a target business) and prospective
target businesses execute agreements with us waiving any right, title, interest or claim of any kind they may have in or to any monies
held in the trust account, there is no guarantee that they will execute such agreements. Nor is there any guarantee that, even if such
entities execute such agreements with us, they will not seek recourse against the trust account or that a court would conclude that such
agreements are legally enforceable.

 Each
of our initial shareholders and our Sponsor has agreed to waive its rights to participate in any liquidation of our trust account or
other assets with respect to the insider shares and private units and to vote their insider shares, private shares in favor of any dissolution
and plan of distribution which we submit to a vote of shareholders. There will be no distribution from the trust account with respect
to our warrants or rights, which will expire worthless.

 If
we are unable to complete an initial business combination and expend all of the net proceeds of the IPO, other than the proceeds deposited
in the trust account, and without taking into account interest, if any, earned on the trust account, the initial per-share distribution
from the trust account would be $10.10.

 The
proceeds deposited in the trust account could, however, become subject to the claims of our creditors which would be prior to the claims
of our public shareholders. Although we will seek to have all vendors, including lenders for money borrowed, prospective target businesses
or other entities we engage execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held
in the trust account for the benefit of our public shareholders, there is no guarantee that they will execute such agreements or even
if they execute such agreements that they would be prevented from bringing claims against the trust account, including but not limited
to, fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability
of the waiver, in each case in order to gain an advantage with a claim against our assets, including the funds held in the trust account.
If any third party refused to execute an agreement waiving such claims to the monies held in the trust account, we would perform an analysis
of the alternatives available to us if we chose not to engage such third party and evaluate if such engagement would be in the best interest
of our shareholders if such third party refused to waive such claims. Examples of possible instances where we may engage a third party
that refused to execute a waiver include the engagement of a third party consultant whose particular expertise or skills are believed
by management to be significantly superior to those of other consultants that would agree to execute a waiver or in cases where management
is unable to find a provider of required services willing to provide the waiver. In any event, our management would perform an analysis
of the alternatives available to it and would only enter into an agreement with a third party that did not execute a waiver if management
believed that such third party's engagement would be significantly more beneficial to us than any alternative. In addition, there
is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any
negotiations, contracts or agreements with us and will not seek recourse against the trust account for any reason.

 Our
Sponsor has agreed that, if we liquidate the trust account prior to the consummation of a business combination, it will be liable to
pay debts and obligations to target businesses or vendors or other entities that are owed money by us for services rendered or contracted
for or products sold to us in excess of the net proceeds of the IPO not held in the trust account, but only to the extent necessary to
ensure that such debts or obligations do not reduce the amounts in the trust account and only if such parties have not executed a waiver
agreement. However, we cannot assure you that he will be able to satisfy those obligations if he is required to do so. Accordingly, the
actual per-share distribution could be less than $10.10 due to claims of creditors. Additionally, if we are forced to file a bankruptcy
case or an involuntary bankruptcy case is filed against us which is not dismissed, the proceeds held in the trust account could be subject
to applicable bankruptcy law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over
the claims of our shareholders. To the extent any bankruptcy claims deplete the trust account, we cannot assure you we will be able to
return to our public shareholders at least $10.10 per share.

 Competition

 In
identifying, evaluating and selecting a target business, we may encounter intense competition from other entities having a business objective
similar to ours. Many of these entities are well established and have extensive experience identifying and effecting business combinations
directly or through affiliates. Many of these competitors possess greater technical, human and other resources than us and our financial
resources will be relatively limited when contrasted with those of many of these competitors. While we believe there may be numerous
potential target businesses that we could acquire with the net proceeds of the IPO, our ability to compete in acquiring certain sizable
target businesses may be limited by our available financial resources.

 The
following also may not be viewed favorably by certain target businesses:

 our
 obligation to seek shareholder approval of a business combination or obtain the necessary financial information to be sent to shareholders
 in connection with such business combination may delay or prevent the completion of a transaction;

 our
 obligation to redeem public shares held by our public shareholders may reduce the resources available to us for a business combination;

 may require us to file a new listing application and meet its initial listing requirements to maintain the listing of our securities
 following a business combination;

 our
 outstanding warrants, rights and the potential future dilution they represent;

 our
 obligation to pay the deferred underwriting discounts and commissions to EF Hutton, division of Benchmark Investments, LLC upon consummation
 of our initial business combination;

 our
 obligation to either repay or issue units upon conversion of up to $500,000 of working capital loans that may be made to us by our
 initial shareholders, officers, directors or their affiliates;

 our
 obligation to register the resale of the insider shares, as well as the private units (and underlying securities) and any securities
 issued to our initial shareholders, officers, directors or their affiliates upon conversion of working capital loans; and

 the
 impact on the target business' assets as a result of unknown liabilities under the securities laws or otherwise depending on
 developments involving us prior to the consummation of a business combination.

 Any
of these factors may place us at a competitive disadvantage in successfully negotiating a business combination. Our management believes,
however, that our status as a public entity and potential access to the United States public equity markets may give us a competitive
advantage over privately-held entities having a similar business objective as ours in acquiring a target business with significant growth
potential on favorable terms.

 If
we succeed in effecting a business combination, there will be, in all likelihood, intense competition from competitors of the target
business. We cannot assure you that, subsequent to a business combination, we will have the resources or ability to compete effectively.

 Facilities

 We
maintain our principal executive office at 1 Commonwealth Lane, #03-20, Singapore, 149544. The cost for this space is provided to us
by Ms. Yeung Po Yi, as part of the $10,000 per month payment we make to it for office space and related services. We consider our current
office space adequate for our current operations.

 Employees

 We
have two executive officers. These individuals are not obligated to devote any specific number of hours to our matters and intend to
devote only as much time as they deem necessary to our affairs. The amount of time they will devote in any time period will vary based
on whether a target business has been selected for the business combination and the stage of the business combination process the company
is in. Accordingly, once management locates a suitable target business to acquire, they will spend more time investigating such target
business and negotiating and processing the business combination (and consequently spend more time to our affairs) than they would prior
to locating a suitable target business. We presently expect our executive officers to devote such amount of time as they reasonably believe
is necessary to our business (which could range from only a few hours a week while we are trying to locate a potential target business
to a majority of their time as we move into serious negotiations with a target business for a business combination). We do not intend
to have any full time employees prior to the consummation of a business combination.

 ITEM
 1A.

 RISK
 FACTORS

 As
a smaller reporting company we are not required to make disclosures under this Item.

 ITEM
 1B.

 UNRESOLVED
 STAFF COMMENTS

 Not
applicable.

 ITEM
 1C.

 CYBERSECURITY

 We
are a SPAC with no business operations. Since our IPO, our sole business activity has been identifying and evaluating suitable acquisition
transaction candidates. Therefore, we do not consider that we face significant cybersecurity risk and have not adopted any cybersecurity
risk management program or formal processes for assessing cybersecurity risk. Our board of directors is generally responsible for the
oversight of risks from cybersecurity threats, if there is any. We have not encountered any cybersecurity incidents since our IPO.

 ITEM
 2.

 PROPERTIES

 We
do not own any real estate or other physical properties materially important to our operations. We maintain our principal executive offices
at 1 Commonwealth Lane, #03-20, Singapore, 149544. The cost for this space is provided to us by Ms. Yeung Po Yi, as part of the $10,000
per month payment we make to it for office space and related services. We consider our current office space adequate for our current
operations.

 ITEM
 3.

 LEGAL
 PROCEEDINGS

 We
may be subject to legal proceedings, investigations and claims incidental to the conduct of our business from time to time. We are not
currently a party to any material litigation or other legal proceedings brought against us. We are also not aware of any legal proceeding,
investigation or claim, or other legal exposure that has a more than remote possibility of having a material adverse effect on our business,
financial condition or results of operations.

 ITEM
 4.

 MINE
 SAFETY DISCLOSURES

 Not
Applicable.

 part
II

 ITEM
 5.

 MARKET
 FOR REGISTRANT'S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 Our
units began to trade on the Nasdaq Capital Market, or Nasdaq, under the symbol "HHGCU" on September 23, 2021. The ordinary
shares, warrants and rights comprising the units began separate trading on Nasdaq on November 11, 2021, under the symbols "HHGC",
"HHGCW" and "HHGCR", respectively.

 Holders
of Record

 As
of March 28, 2024, there were 370 of our ordinary shares issued and outstanding held by [ ] shareholders of record.
The number of record holders was determined from the records of our transfer agent and does not include beneficial owners of ordinary
shares whose shares are held in the names of various security brokers, dealers, and registered clearing agencies.

 Dividends

 We
have not paid any cash dividends on our ordinary shares to date and do not intend to pay cash dividends prior to the completion of an
initial business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital
requirements and general financial condition subsequent to completion of a business combination. The payment of any dividends subsequent
to a business combination will be within the discretion of our board of directors at such time. It is the present intention of our board
of directors to retain all earnings, if any, for use in our business operations and, accordingly, our board of directors does not anticipate
declaring any dividends in the foreseeable future. In addition, our board of directors is not currently contemplating and does not anticipate
declaring any share dividends in the foreseeable future. Further, if we incur any indebtedness, our ability to declare dividends may
be limited by restrictive covenants we may agree to in connection therewith.

 Securities
Authorized for Issuance Under Equity Compensation Plans

 None.

 Recent
Sales of Unregistered Securities

 None.

 Use
of Proceeds

 On
September 23, 2021, the Company consummated its IPO of 5,750,000 Units, which includes the full exercise of the over-allotment option.
Each Unit consists of one ordinary share ("Ordinary Share"), one redeemable warrant and one right. Each redeemable warrant
entitles the holder thereof to purchase three-fourths (3/4) of one Ordinary Share at a price of $11.50 per whole share, and each ten
Rights entitle the holder thereof to receive one Ordinary Share at the closing of a business combination. The Units were sold at an offering
price of $10.00 per Unit, generating gross proceeds of $57,500,000. Simultaneously with the closing of the IPO, the Company consummated
a Private Placement of 255,000 units at a price of $10.00 per Private Unit, generating total proceeds of $2,550,000. A total of $58,075,000
of the net proceeds from the sale of Units in the IPO (including the over-allotment option units) and the Private Placements were placed
in a trust account established for the benefit of the Company's public shareholders.

 As
of December 31, 2022, a total of $34,454,043 was held in a trust account established for the benefit of the Company's public shareholders,
which included $58,075,000 of the net proceeds from the IPO (including the exercise of the over-allotment option) and the Private Placements,
$617,502 of subsequent dividend, $36,321 of business combination extension fee and offset by $24,274,780 of 2,393,594 Public Shares redemption.

 As
of December 31, 2021, a total of $58,076,283 was held in a trust account established for the benefit of the Company's public shareholders,
which included $58,075,000 of the net proceeds from the IPO (including the exercise of the over-allotment option) and the Private Placements,
$960 of subsequent interest income and $324 of gross unrealized holding gain.

 The
private units are identical to the units sold in the IPO except that the private warrants will be non-redeemable and may be exercised
on a cashless basis, in each case so long as they continue to be held by our Sponsor or its permitted transferees. Additionally, because
the Private Units were issued in a private transaction, our Sponsor and its permitted transferees will be allowed to exercise the warrants
included in the Private Units for cash even if a registration statement covering the Ordinary Shares issuable upon exercise of such warrants
is not effective and receive unregistered Ordinary Shares. Additionally, our Sponsor agreed not to transfer, assign or sell any of the
Private Units or underlying securities (except to the same permitted transferees as the insider shares and provided the transferees agree
to the same terms and restrictions as the permitted transferees of the insider shares must agree to, each as described above) until the
completion of the Company's initial business combination. The Sponsor was granted certain demand and piggyback registration rights
in connection with the Private Units.

 As
of December 31, 2021, we paid approximately $226,411 for other costs and expenses related to our IPO, and a total of $805,000 in underwriting
discounts and commissions, not including the deferred underwriting commissions which should equal to the greater of (x) $575,000 or (y)
4.5% (or 0.5% if such funds are introduced by our sponsor or management) of the cash remaining in the trust account plus 0.5% of the
cash redeemed from the trust account upon the Company's completion of the initial business combination, subject to a maximum amount
of $1,615,000 payable at the consummation of business combination.

 As
of December 31, 2023, a total of $35,909,651 was held in a trust account established for the benefit of the Company's public
shareholders. On each of September 21, 2022, October 31, 2022, November 28, 2022, December 21, 2022, January 20, 2023, February 21,
2023, March 21, 2023, April 21, 2023, May 22, 2023, June 23, 2023 and July 23, 2023, and August 22, 2023, HHG deposited the amount
of $9,080.20 into the Trust Account to extend the available time to complete a business combination for an additional one month with
each such Extension Payment, and on each of September 22, 2023, October 20, 2023, November 22, 2023, December 22, 2023, January 23,
2024, February 23, 2024 and March 22, 2024, HHGC deposited the amount of $7,985.40 into the Trust Account to extend the available time to complete a
business combination for an additional one month.

 For
additional information on the use of the proceeds generated in our initial public offering, see below Part II, Item 7 – Management's
Discussion and Analysis of Financial Condition and Results of Operations of this Form 10-K.

 Purchases
of Equity Securities by the Issuer and Affiliated Purchasers

 None.

 ITEM
 6.

 [RESERVED]

 ITEM
 7.

 MANAGEMENT'S
 DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 The
following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial
statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set
forth below includes forward-looking statements that involve risks and uncertainties.

 Overview

 We
are a blank check company incorporated in the British Virgin Islands on July 15, 2020 with limited liability (meaning our public shareholders
have no liability, as shareholders of the Company, for the liabilities of the Company over and above the amount paid for their shares)
to serve as a vehicle to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar
business combination with one or more target businesses. Our efforts to identify a prospective target business will not be limited to
a particular industry or geographic location. We intend to utilize cash derived from the proceeds of the Initial Public Offering, our
securities, debt or a combination of cash, securities and debt, in effecting a business combination.

 A
resolution was passed on September 20, 2021 at the Company's Annual General Meeting to amend the Company's investment management
trust agreement by and between the Company and the Trustee, to extend the date on which to commence liquidating the Trust Account established
in connection with the Company's IPO twelve (12) times for an additional one (1) month each time from September 23, 2022 to September
23, 2023 by depositing into the trust account $0.0155 for each Public Share that has not been redeemed (or an aggregate of $88,867 if
there are no redemptions) (the "Extension Payment") for each one-month extension in the event the Company has not consummated
a business combination by the Extended Termination Date. On September 21, 2023, the shareholders of the Company approved an amended and
restated memorandum and articles of association (the "Charter Amendment II"), giving the Company the right to extend the
date by which it has to complete a business combination up to twelve (12) times for an additional one (1) month each time, from September
23, 2023 to up to September 23, 2024. The Company has extended the amount of available time
to complete a business combination until April 23, 2023.

 On
March 15, 2023, the Company has entered into non-binding letter of intent with Perfect Hexagon Group Limited.

 On
August 2, 2023, the Company entered into an agreement and plan of merger (the "Merger Agreement") with Perfect Hexagon Holdings
Limited, a British Virgin Islands business company and wholly owned subsidiary of the Company ("Purchaser"), Perfect Acquisitions
Limited, a British Virgin Islands business company and wholly owned subsidiary of Purchaser ("Merger Sub"), and Perfect Hexagon
Group Limited, a British Virgin Islands business company ("Perfect Hexagon"). Upon the closing of the transactions contemplated
by the Merger Agreement, (a) the Company will be merged with and into Purchaser (the "Reincorporation Merger"), with Purchaser
surviving the Reincorporation Merger, and (b) Merger Sub will be merged with and into Perfect Hexagon (the "Acquisition Merger"),
with Perfect Hexagon surviving the Acquisition Merger as a direct wholly owned subsidiary of Purchaser (collectively, the "Merger"
or the "Business Combination"). Following the Business Combination, Purchaser will be a publicly traded company listed on
a stock exchange in the United States. Pursuant to the terms of the Merger Agreement, the aggregate consideration to be paid at the closing
of the Business Combination to existing shareholders of the Investor is $990,000,000 (the "Merger Consideration"), which
will be paid in 99,000,000 newly issued ordinary shares of the Purchaser at a deemed price of $10.00 per share.

 Results
of Operations

 Our
entire activity from inception up to September 23, 2021 was in preparation for the initial public offering. Since the initial public
offering, our activity has been limited to the evaluation of business combination candidates, and we will not be generating any operating
revenues until the closing and completion of our initial business combination. We expect to incur increased expenses as a result of being
a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses. We expect
our expenses to increase substantially after this period.

 For
the years ended December 31, 2023, we had a net income of $1,372,581, which was comprised of interest income from our cash in bank and
dividend income earned in investments held in Trust Account of $1,715,722, sundry income of $210,000 and offset by general and administrative
expenses of $553,141.

 (As
Restated) For the years ended December 31, 2022,
we had a net income-tax of $63,207, which was comprised of interest income from our cash in bank and dividend income earned in investments
held in Trust Account of $617,150 and general and offset by administrative expenses of $553,943.

 Results
of Operations for the Three and Nine Months ended September 30, 2023 (As Restated)

 For
the three months ended September 30, 2023, we had a net income of $498,167, which was comprised of interest income from dividend income
earned in investments held in Trust Account of $459,597 and other income from waiver of unpaid administrative service monthly fee of
$210,000 offset by general and administrative expenses of $171,430.

 For
the nine months ended September 30, 2023, we had a net income of $996,599, which was comprised of interest income from our cash in bank
of $3,471 and dividend income earned in investments held in Trust Account of $1,240,982, and other income from waiver of unpaid administrative
service monthly fee of $210,000 offset by general and administrative expenses of $457,854.

 Results
of Operations for the Three and Six Months ended June 30, 2023 (As Restated)

 For
the three months ended June 30, 2023, we had a net income of $211,939, which was comprised of interest income from our cash in bank and
dividend income earned in investments held in Trust Account of $416,318, offset by general and administrative expenses of $204,379.

 For
the six months ended June 30, 2023, we had a net income of $498,432, which was comprised of interest income from our cash in bank and
dividend income earned in investments held in Trust Account of $784,856, offset by general and administrative expenses of $286,424.

 Results
of Operations for the Three Months ended March 31, 2023 (As Restated)

 For
the three months ended March 31, 2023, we had a net income of $286,493, which
was comprised of interest income from our cash in bank and dividend income earned in investments held in Trust Account of $368,538, offset
by general and administrative expenses $82,045.

and Capital Resources

 On
September 23, 2021, we consummated the initial public offering of 5,000,000 Public Units at a price of $10.00 per unit, generating gross
proceeds of $50,000,000. Simultaneously, the underwriters exercised the over-allotment option in full and purchased additional 750,000
units at a price of $10.00 per unit, generating gross proceeds of $7,500,000. Simultaneously with the closing of the initial public offering,
we consummated the sale of 237,000 Private Units, at a price of $10.00 per unit, generating gross proceeds of $2,370,000.

 Following
the initial public offering and the exercise of the over-allotment option, a total of $58,075,000 was placed in the trust account. We
incurred $1,031,411 in initial public offering related costs, including $805,000 of underwriting fees and $226,411 of initial public
offering costs.

 We
intend to use substantially all of the net proceeds of the initial public offering, including the funds held in the trust account, to
acquire a target business or businesses and to pay our expenses relating thereto. To the extent that our capital stock is used in whole
or in part as consideration to effect our business combination, the remaining proceeds held in the trust account, as well as any other
net proceeds not expended, will be used as working capital to finance the operations of the target business. Such working capital funds
could be used in a variety of ways including continuing or expanding the target business' operations, for strategic acquisitions
and for marketing, research and development of existing or new products. Such funds could also be used to repay any operating expenses
or finders' fees which we had incurred prior to the completion of our business combination if the funds available to us outside
of the trust account were insufficient to cover such expenses.

 We
intend to use the funds held outside the trust account primarily to identify and evaluate target businesses, perform business due diligence
on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their
representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate
and complete a business combination.

 As
of December 31, 2023, we had cash of $16,014. Until the consummation of the initial public offering, the Company's only source
of liquidity was an initial purchase of ordinary shares by the initial shareholders, monies loaned by the related party under an unsecured
promissory note.

 On
September 19, 2022, the shareholders of the Company approved an amended and restated memorandum and articles of association (the "Charter
Amendment"), giving the Company the right to extend the date by which it has to complete a business combination up to twelve (12)
times for an additional one (1) month each time, from September 23, 2022 up to September 23, 2023. On September 21, 2023, the shareholders
of the Company approved an amended and restated memorandum and articles of association (the "Charter Amendment II"), giving
the Company the right to extend the date by which it has to complete a business combination up to twelve (12) times for an additional
one (1) month each time, from September 23, 2023 to up to September 23, 2024. We may begin preliminary due diligence of a target business
in connection with an indication of interest, we intend to undertake in-depth due diligence, depending on the circumstances of the relevant
prospective acquisition, only after we have negotiated and signed a letter of intent or other preliminary agreement that addresses the
terms of our initial business combination. However, if our estimate of the costs of undertaking in-depth due diligence and negotiating
our initial business combination is less than the actual amount necessary to do so, or the amount of interest available to use from the
trust account is minimal as a result of the current interest rate environment, we may be required to raise additional capital, the amount,
availability and cost of which is currently unascertainable. In this event, we could seek such additional capital through loans or additional
investments from members of our management team, but such members of our management team are not under any obligation to advance funds
to, or invest in, us. In the event that the business combination does not close, we may use a portion of the working capital held outside
the trust account to repay such loaned amounts, but no proceeds from our trust account would be used for such repayment. Such loans would
be evidenced by promissory notes. The notes would either be paid upon consummation of our business combination, without interest, or,
at the lender's discretion, up to $500,000 of the notes may be converted upon consummation of our business combination into additional
Private Units at a price of $10.00 per unit. The terms of such loans by our initial shareholders, officers and directors, if any, have
not been determined and no written agreements exist with respect to such loans.

 Additionally, the Charter Amendments also allowed the holders of the Public Shares to redeem the shares when the Directors of the Company
propose any amendment to the Company's amended and restated memorandum and article of association that would affect the substance
or timing of the redemption of the Public Shares. Accordingly, on September 19, 2022, 2,393,594 Public Shares were redeemed for the pro-rata
share of the deposits then in the Trust Account. On September 22, 2023, 32,845 Public Shares were redeemed for the pro-rata share of
the deposits then in the Trust Account.

 Along
with the Company's Charter Amendment, Charter Amendment II, on each of September 21, 2022, October 31, 2022, November 28,
2022, December 21, 2022, January 20, 2023, February 21, 2023, March 21, 2023, April 21, 2023,
May 23, 2023, June 23, 2023 and July 23, 2023, the Company had been deposited $9,080 into the Trust Account in order to
extend the amount of available time to complete a business combination until August 23,
2023. On each of August 23, 2023, September 23, 2023, October 20, 2023, November
22, 2023, December 22, 2023, January 23, 2024, February 23, 2024 and March 20, 2024, the Company had deposited $7,985 into the
Trust Account in order to extend the amount of available time to complete a business combination until April 23, 2024.

 For
the year ended December 31, 2023, the Company incurred net income of $1,372,581 and had negative cash provided by operating activities
of $408,273. As of December 31, 2023, the Company had working capital deficit of $295,664.
We may need to raise additional capital through loans or additional investments from its Sponsor or third parties.

 In
connection with the Company's assessment of going concern in accordance with the authoritative guidance in ASU 2014-15, "Disclosures
of Uncertainties about an Entity's Ability to Continue as a Going Concern," management has concluded that the Company
has incurred net cash used in operating activities and determined that the mandatory liquidation and subsequent dissolution, should the
Company be unable to raise additional funds to meet its obligations and complete a Business Combination, raises substantial doubt about
the Company's ability to continue as a going concern. The Company has until April 23, 2023
to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time.
If a Business Combination is not consummated by this date without an extension to the acquisition period, there will be a mandatory liquidation
and subsequent dissolution. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required
to liquidate after September 23, 2024. Pursuant to the Trust Amendment II, the Company has the right to extend the time to complete
a business combination twelve (12) times for an additional one (1) month each time from September 23, 2023, to September 23, 2024, by
depositing $0.0333 for each issued and outstanding Company ordinary share issued in the IPO for each one-month extension (only non-waiving Public Share).

 Accordingly,
the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required
to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending
the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will
be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company's ability
to continue as a going concern through one year from the date of these consolidated financial statements if a Business Combination is
not consummated. These consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets
or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

and Capital Resources for the Three and Nine Months ended September 30, 2023 (As Restated)

 For
the nine months ended September 30, 2023, the Company generated net income of $996,599, but had cash used in operating activities of
$281,696. As of September 30, 2023, the Company had cash of $6,546 with working capital deficit of $176,423. We may need to raise additional
capital through loans or additional investments from its Sponsor or third parties.

and Capital Resources for the Three and Six Months ended June 30, 2023 (As Restated)

 For
the six months ended June 30, 2023, the Company generated net income of $498,432, but had cash used in operating activities of $235,004.
As of June 30, 2023, the Company had cash of $39,384 with working capital deficit of $188,847. We may need to raise additional capital
through loans or additional investments from its Sponsor or third parties.

and Capital Resources for the Three and Months ended March 31, 2023 (As Restated)

 For
the three months ended March 31, 2023, the Company generated net income of $286,493 but had cash used in operating activities of $107,702.
As of March 31, 2023, the Company had cash of $193,927 with working capital deficit of $42,109. We may need to raise additional capital
through loans or additional investments from its Sponsor or third parties.

 Off-balance
Sheet Financing Arrangements

 We
have no obligations, assets or liabilities which would be considered off-balance sheet arrangements as of December 31, 2023 and 2022.
We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred
to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We
have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or
commitments of other entities, or purchased any non-financial assets.

 Contractual
Obligations

 We
do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities other than an agreement
to pay our Sponsor a monthly fee of $10,000 for general and administrative services, including office space, utilities and administrative
services to the Company. We began incurring these fees on October 1, 2021. On September 4, 2023, the Sponsor agreed to waive monthly
fee of $10,000 commencing from July 1, 2023. Also, we are committed to the below:

 Registration
Rights

 The
holders of the insider shares, the Private Units (and their underlying securities) and the warrants that may be issued upon conversion
of any working capital loans (and their underlying securities) are entitled to registration rights pursuant to a registration rights
agreement signed on September 20, 2021. The holders of a majority of these securities will be entitled to make up to two demands that
the Company register such securities. The holders of the majority of the insider shares can elect to exercise these registration rights
at any time commencing three months prior to the date on which these ordinary shares are to be released from escrow. The holders of a
majority of the Private Units and warrants issued in payment of any working capital loans made to the Company (or underlying securities)
can elect to exercise these registration rights at any time after the Company consummates a business combination. In addition, the holders
will have certain "piggy-back" registration rights with respect to registration statements filed subsequent to the completion
of a business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 Underwriting
Agreement

 The
underwriters were entitled to an underwriting fee of 3.2% of the gross proceeds from offering to the maximum of $1,615,000. A total of
$805,000 was paid upon the closing of the Initial Public Offering. At the closing of any Business Combination, the Underwriters will
receive a cash payment equal to the greater of: (i)$575,000 or (ii) a fee equal to 4.5% (or 0.5% with respect to investors in the Offering
introduced to the Underwriters by the Company's sponsor, or Company's management, subject to a total maximum underwriting
fee of $1,615,000.

 Critical
Accounting Estimates

 The
preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United
States of America ("U.S. GAAP") requires management to make estimates and assumptions that affect the reported amounts of
assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses
during the periods reported. Actual results could materially differ from those estimates. The Company has not identified the critical
accounting estimates.

 Recent
Accounting Standards

 In
December 2023, the FASB issued Accounting Standards Update 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosure"
("ASU 2023-09"). ASU 2023-09 mostly requires, on an annual basis, disclosure of specific categories in an entity's
effective tax rate reconciliation and income taxes paid disaggregated by jurisdiction. The incremental disclosures may be presented on
a prospective or retrospective basis. The ASU is effective for fiscal years beginning after December 15, 2024 with early adoption permitted.
The Company is currently assessing the impact, if any, that ASU 2023-09 would have on its financial position, results of operations or
cash flows.

 Other
than the above, there are no other recently issued accounting standards which are applicable to the Company.

 ITEM
 7A.

 QUANTITATIVE
 AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 We
are a smaller reporting company and are not required to provide the information otherwise required under this item.

 ITEM
 8.

 FINANCIAL
 STATEMENTS AND SUPPLEMENTARY DATA

 Our
financial statements and the notes thereto begin on page F-1 of this Annual Report.

 ITEM
 9.

 CHANGES
 IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 None.

 ITEM
 9A.

 CONTROLS
 AND PROCEDURES

 Evaluation
of Disclosure Controls and Procedures

 Disclosure
controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed
under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time period specified in the
SEC's rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated
and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely
decisions regarding required disclosure. Our management evaluated, with the participation of our current chief executive officer and
chief financial officer (our "Certifying Officers"), the effectiveness of our disclosure controls and procedures as of December
31, 2023, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial
Officer concluded that, as of December 31, 2023, our disclosure controls and procedures were not effective due to the material weaknesses in our
control environment which resulted in restatements of financial year ended 2022 and interim financial statement 2023 due to inadequate
oversight over the accounting for interest earned on investments held in the Trust Account and related to a lack of accounting staff with
appropriate knowledge of U.S. GAAP and SEC reporting.

 Management
plans to remediate the material weakness by enhancing our processes to identify and appropriately apply applicable accounting
requirements and increased communication among our personnel and third-party professionals with whom we consult regarding accounting
applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these
initiatives will ultimately have the intended effects. For a discussion of management's consideration of the material weakness
identified related to our accounting for interest earned on investments held in the Trust Account and classification of
administrative service cash flow in the consolidated statement of cash flows, see "Note
2—Restatement of Previously Issued Financial Statements" to the accompanying financial statements.

 Management's
Report on Internal Controls Over Financial Reporting

 As
required by SEC rules and regulations implementing Section 404 of the Sarbanes-Oxley Act (as defined in Rules 13a-15(e) and 15- d-15(e)
under the Securities Exchange Act of 1934, as amended), our management is responsible for establishing and maintaining adequate internal
control over financial reporting. Our internal control over financial reporting is designed to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of our financial statements for external reporting purposes in accordance
with GAAP. Our internal control over financial reporting includes those policies and procedures that:

 (1)
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of
the assets of our company,

 (2)
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance
with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors,
and

 (3)
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that
could have a material effect on the financial statements.

 Because
of its inherent limitations, internal control over financial reporting may not prevent or detect errors or misstatements in our financial
statements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate
because of changes in conditions, or that the degree or compliance with the policies or procedures may deteriorate. Management assessed
the effectiveness of our internal control over financial reporting at December 31, 2023. In making these assessments, management used
the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control — Integrated
Framework (2013). Based on our assessments and those criteria, management determined that we did not maintain effective internal control
over financial reporting as of December 31, 2023 due to the material weakness described above. For additional information, see "–
 Evaluation of Disclosure Controls and Procedures."

 This
Annual Report on Form 10-K does not include an attestation report of internal controls from our independent registered public accounting
firm due to our status as an emerging growth company under the JOBS Act.

 Changes
in Internal Control over Financial Reporting

 Other
than the matter disclosed above, there was no change in our internal control over financial reporting that occurred during the quarter ended December 31, 2023 that has materially affected, or is reasonably likely to materially
affect, our internal control over financial reporting.

 ITEM
 9B.

 OTHER
 INFORMATION

 None.

 ITEM
 9C.

 DISCLOSURE
 REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

 Not
applicable.

 part
III

 ITEM
 10.

 DIRECTORS,
 EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 The
following table sets forth information about our directors and executive officers as of the date of this report:

 Name

 Age

 Position

 Chee
 Shiong (Keith) Kok

 and Chief Executive Officer

 Shuk
 Man (Lora) Chan

 Chief
 Financial Officer

 Kym
 Hau

 Weiyi
 Di

 Independent

 Tzu
 Fei (Philip) Ting

 Independent

 Below
is a summary of the business experience of each of our executive officers and directors:

 Chee
Shiong (Keith) Kok. Mr. Chee Shiong (Keith) Kok has been our director and Chief Executive Officer since June 2021. Mr. Kok has
over two decades of experience in finance, mergers & acquisitions, risk management, business strategy integrations, divestitures,
and hands-on operational expertise with extensive government and business network, particularly in Asia. Since September 2019, Mr. Kok
has been serving as the director and the chief executive officer of EPL Exhibition Sdn. Bhd., an exhibition organizer. From June 2017
to August 2019, Mr. Kok served as the chief finance officer of EN Projects Sdn. Bhd., a company engaged in managing government related
aerospace and maritime exhibitions and was recognized as the Best International Exhibition organizer for LIMA by the then Malaysia Prime
Minister in 2019. From January 2013 to March 2017, Mr. Kok served as the head transaction banking corporate banking, and subsequently,
the head business banking of Standard Chartered Bank Malaysia. During Mr. Kok's time with Standard Chartered Bank Malaysia, he
led the bank to win the Best Cash Management Deal for Corporate Banking within Standard Chartered Bank worldwide in 2014, Best Liquidity
Management Deal in Malaysia in 2015 by Asset Triple A and won best Top SME supporter in Malaysia with CGC (Credit Guarantee Corporation)
in 2016. From August 2007 to January 2013, Mr. Kok served as the regional head transaction banking for the Asian & Oceania region
(excluding North Asia) of Bank of Tokyo Mitsubishi-UFJ Ltd (Singapore Branch) ("BTMU"). During Mr. Kok's time with
BTMU, he assisted the International Enterprise Singapore, a division of Singapore Government to develop government guarantee scheme (SPRING)
to assist the small and medium enterprises during the Global Financial Crisis in 2008. Mr. Kok was also instrumental in developing the
Global Transaction Banking Division in BTMU and led BTMU to be the first bank in the world to conclude electronic Letter of Credit (LC)
Discounting and the first bank in Singapore to deal with processing electronic LC. From January 2007 to August 2007, Mr. Kok served as
the vice president in the trade division of The Hongkong and Shanghai Banking Corporation, a banking corporation. From December 2005
to January 2007, Mr. Kok served as the assistant vice president of Citibank Berhad in Malaysia, a banking corporation. From 2002 to 2005,
Mr. Kok was engaged in his own consultancy business and worked in various local Malaysian companies. From 1996 to 2002, Mr. Kok served
in various positions in corporate banking division at Standard Chartered Bank Malaysia. Mr. Kok received a bachelor's of science
degree in banking and finance from University of London in 1995. Mr. Kok also obtained ICC Certificate of Achievement Upskill 600 and
M5 Rules & Regulations For Financial Advisory Services, in 2007 and 2008, respectively.

 Shuk
Man (Lora) Chan. Ms. Shuk Man (Lora) Chan has been our Chief Financial Officer since June 2021. Ms. Chan has been serving as
the company secretary and the authorized representative of China Tontine Wines Group Limited (HKG.0389), a company engaged in the wine
business in the PRC, since January 2021. From June 2016 to May 2020, Ms. Chan served as an investment director and then subsequently
became the company secretary and the authorized representative of Evershine Group Holdings Limited (HKG.8022), a company principally
engaged in the trading business, cemetery business, property development and investment, mobile application business and also provision
of money lending business. From May 2001 to May 2015, Ms. Chan was providing audit, assurance and consultancy services at UHY Vocation
HK CPA Limited with her last position as a senior director. From 1995 to 2001, Ms. Chan was engaged in a family business in Thailand
where she was responsible for providing investment analysis. From 1994 to 1995, Ms. Chan served as a senior officer of Merchant and Corporate
Banking Unit of Credit Department at Generale Belgian Bank Hong Kong, a subsidiary of Generale Bank, Belgium. From 1993 to 1994, Ms.
Chan served as a credit analyst at Dai-Ichi Kangyo Limited, the Hong Kong Branch, a subsidiary of Dai-Ichi Kangyo Bank, Japan. Ms. Chan
received a bachelor's degree of business administration in accounting from The Coventry University, United Kingdom and a MBA degree
(major in banking) from The University of Stirling, United Kingdom in 1991 and 1992, respectively. Ms. Chan is a fellow member of the
Hong Kong Institute of Certified Public Accountants, Association of Chartered Certified Accountants, the Taxation Institute of Hong Kong,
a Chartered Tax Adviser (Hong Kong) and a member of American Institute of CPAs (International Associate).

 Kym
Hau. Ms. Kym Hau has been our director since June 2021. Since 2014, Ms. Hau has been working at Messrs. Wan Yeung Hau & Co.,
Solicitors, a law firm. Ms. Hau joined Messrs. Wan Yeung Hau & Co., Solicitors in June 2014 where she served as a legal consultant
and was then promoted to a partner in June 2015. Since November 2020, Ms. Hau has been a legal consultant of Messrs. Wan Yeung Hau &
Co., Solicitors. Since March 2019, Ms. Hau has been a director of Grey Bear Capital Limited, a company engaged in the provision of general
consulting services. Ms. Hau received a bachelor's degree in Laws and a Postgraduate Certificate in Laws from The City University
of Hong Kong in 2003 and 2004, respectively.

 Weiyi
Di. Mr. Weiyi Di has been our independent director since June 2021. Since June 2019, Mr. Di has been the director and the chief
executive officer of Polo Lubricants Company Limited, a company engaged in producing engine oils. Since 2002, Mr. Di has been the chief
executive officer of Luroda Lubricants Wuxi Co., Ltd, a company engaged in the research and development, manufacturing, and distribution
of lubricants. From 1994 to 2004, Mr. Di served as the sales manager and was subsequently promoted as the managing director of Wuxi Jiangnan
Refinery Co., Ltd, a company engaged in oil refinery. Mr. Di obtained his master's degree in executive master of business administration
from Tsinghua University in 2010.

 Tzu
Fei (Philip) Ting. Mr. Tzu Fei (Philip) Ting has been our independent director since June 2021. Since September 2010, he has
been the founding partner of Philip Ting & Kwan law firm with specific focus on fund advisory, property, technology and renewable
energy sectors. Since November 2020, Mr. Ting has been a director of Tableapp Sdn. Bhd., a company engaged in the online reservation
of high end restaurants in Malaysia. Mr. Ting is also a founding partner of FunNow Sdn. Bhd., an application software products company,
which was founded in Malaysia in July 2018. Since October 2015, Mr. Ting has been a managing director at Clearbrook Global Advisers LLC,
a global investment advisory company, which advises on strategic fund raising opportunities in Asia. Since May 2009, Mr. Ting has been
a director of Solarcorp Sdn. Bhd., a company engaged in the generation and sale of solar energy in Malaysia. From October 2006 to August
2007, Mr. Ting completed his pupillage at Skrine, a law firm. From November 2007 to September 2008, Mr. Ting served as a paralegal at
Allen & Overy (Hong Kong), a law firm. From October 2008 to January 2009, Mr. Ting served as a registered foreign lawyer at Richards
Butler in association with Reed Smith (Hong Kong). Mr. Ting obtained a bachelor's degree in Laws from The University of Nottingham,
United Kingdom and a master's degree in law and accounting from The London School of Economics, United Kingdom in 2003 and 2005,
respectively. Mr. Ting was called to the Bar in the United Kingdom, Malaysia and United States in 2004, 2007 and 2008, respectively.
Mr. Ting passed the Chartered Financial Analyst (CFA, Level 1) in 2006.

 We
believe with their vast experience and complementary skillsets, our officers and directors are well qualified to serve as members of
our board.

 Our
directors and officers will play a key role in identifying, evaluating, and selecting target businesses, and structuring, negotiating
and consummating our initial acquisition transaction. Except as described below and under "Conflicts of Interest," none of
these individuals is currently a principal of or affiliated with a public company or blank check company that executed a business plan
similar to our business plan. We believe that the skills and experience of these individuals, their collective access to acquisition
opportunities and ideas, their contacts, and their transaction expertise should enable them to identify successfully and effect an acquisition
transaction, although we cannot assure you that they will, in fact, be able to do so.

 Board
Committees

 The
Board has a standing audit, nominating and compensation committee. The independent directors oversee director nominations. Each audit
committee and compensation committee has a charter.

 Audit
Committee

 The
Audit Committee, which is established in accordance with Section 3(a)(58)(A) of the Exchange Act, monitors the independence of the independent
auditor, reviews and discusses with management and the independent auditor the annual audited financial statements, and recommending
to the board whether the audited financial statements should be included in our Form 10-K, discusses with management and the independent
auditor significant financial reporting issues and judgments made in connection with the preparation of our financial statements; discusses
with management major risk assessment and risk management policies; verifies the rotation of the lead (or coordinates) audit partner
having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law, reviews and
approves all related-party transactions, inquires and discusses with management our compliance with applicable laws and regulations;
pre-approves all audit services and permitted non-audit services to be performed by our independent auditor, including the fees and terms
of the services to be performed; appoints or replaces the independent auditor; determines the compensation and oversight of the work
of the independent auditor (including resolution of disagreements between management and the independent auditor regarding financial
reporting) for the purpose of preparing or issuing an audit report or related work; establishes procedures for the receipt, retention
and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues
regarding our financial statements or accounting policies; and approves reimbursement of expenses incurred by our management team in
identifying potential target businesses.

 The
members of the Audit Committee are Weiyi Di and Tzu Fei (Philip) Ting, each of whom is an independent director under NASDAQ's listing
standards. Tzu Fei (Philip) Ting is the chairperson of the audit committee. The Board has determined that both Fei (Philip) Ting qualify
as an "audit committee financial expert," as defined under the rules and regulations of the SEC.

 Nominating
Committee

 The
Nominating Committee is responsible for overseeing the selection of persons to be nominated to serve on our Board. Specifically, the
Nominating Committee responsible for overseeing the selection of persons to be nominated to serve on our board of directors. On an annual
basis, the Nominating Committee recommends for approval by the Board certain desired qualifications and characteristics for board membership.
Additionally, the Nominating Committee establishes and administers a periodic assessment procedure relating to the performance of the
Board as a whole and its individual members. The Nominating Committee will consider a number of qualifications relating to management
and leadership experience, background and integrity and professionalism in evaluating a person's candidacy for membership on the
Board. The Nominating Committee may require certain skills or attributes, such as financial or accounting experience, to meet specific
board needs that arise from time to time and will also consider the overall experience and makeup of its members to obtain a broad and
diverse mix of board members. The nominating committee does not distinguish among nominees recommended by shareholders and other persons.

 The
members of the Nominating Committee are, Weiyi Di and Tzu Fei (Philip) Ting, each of whom is an independent director under NASDAQ's
listing standards. Tzu
 Fei (Philip) Ting is the chairperson of the Nominating Committee.

 Compensation
Committee

 The
Compensation Committee reviews annually the Company's corporate goals and objectives relevant to the officers' compensation,
evaluates the officers' performance in light of such goals and objectives, determines and approves the officers' compensation
level based on this evaluation; reviews and approves the compensation of all of our other executive officers; reviews our executive compensation
policies and plans; implements and administers our incentive compensation equity-based remuneration plans; assists management in complying
with our proxy statement and annual report disclosure requirements; approves all special perquisites, special cash payments and other
special compensation and benefit arrangements for our executive officers and employees; if required, producing a report on executive
compensation to be included in our annual proxy statement; and reviews, evaluates and recommends changes, if appropriate, to the remuneration
for directors. The Compensation Committee has the authority to delegate any of its responsibilities to subcommittees as it may deem appropriate
in its sole discretion. The chief executive officer of the Company may not be present during voting or deliberations of the Compensation
Committee with respect to his compensation. The Company's executive officers do not play a role in suggesting their own salaries.
Neither the Company nor the Compensation Committee has engaged any compensation consultant who has a role in determining or recommending
the amount or form of executive or director compensation.

 Notwithstanding
the foregoing, as indicated above, no compensation of any kind, including finders, consulting or other similar fees, will be paid to
any of our existing shareholders, including our directors, or any of their respective affiliates, prior to, or for any services they
render in order to effectuate, the consummation of a business combination. Accordingly, it is likely that prior to the consummation of
an initial business combination, the compensation committee will only be responsible for the review and recommendation of any compensation
arrangements to be entered into in connection with such initial business combination.

 The
members of the Compensation Committee are Weiyi Di and Tzu Fei (Philip) Ting, each of whom is an independent director under NASDAQ's
listing standards. Weiyi Di is the chairperson of the Compensation Committee.

 Code
of Ethics

 We
adopted a code of conduct and ethics applicable to our directors, officers and employees in accordance with applicable federal securities
laws. The code of ethics codifies the business and ethical principles that govern all aspects of our business.

 Section
16(a) Beneficial Ownership Reporting Compliance

 Section
16(a) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, requires our executive officers, directors and persons
who beneficially own more than 10% of a registered class of our equity securities to file with the Securities and Exchange Commission
initial reports of ownership and reports of changes in ownership of our ordinary shares and other equity securities. These executive
officers, directors, and greater than 10% beneficial owners are required by SEC regulation to furnish us with copies of all Section 16(a)
forms filed by such reporting persons.

 Based
solely on our review of such forms furnished to us and written representations from certain reporting persons, we believe that all filing
requirements applicable to our executive officers, directors and greater than 10% beneficial owners were filed in a timely manner.

 ITEM
 11.

 EXECUTIVE
 COMPENSATION

 Employment
Agreements

 We
have not entered into any employment agreements with our executive officers, and have not made any agreements to provide benefits upon
termination of employment.

 Executive
Officers and Director Compensation

 No
executive officer has received any cash compensation for services rendered to us. No compensation of any kind, including finders, consulting
or other similar fees, will be paid to any of our existing shareholders, including our directors, or any of their respective affiliates,
prior to, or for any services they render in order to effectuate, the consummation of a business combination. However, such individuals
will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential
target businesses and performing due diligence on suitable business combinations. There is no limit on the amount of these out-of-pocket
expenses and there will be no review of the reasonableness of the expenses by anyone other than our board of directors and audit committee,
which includes persons who may seek reimbursement, or a court of competent jurisdiction if such reimbursement is challenged.

 ITEM
 12.

 SECURITY
 OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS

 The
following table sets forth certain information with respect to the beneficial ownership of our voting securities by (i) each person
who is known by us to be the beneficial owner of more than 5% of our issued and outstanding ordinary shares, (ii) each of our
officers and directors, and (iii) all of our officers and directors as a group as of March 28, 2024. As of March 28, 2024, we had 3,323,561
ordinary shares issued and outstanding.

 Unless
otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all ordinary
shares beneficially owned by them. The following table does not reflect record of beneficial ownership of any ordinary shares issuable
upon exercise of the warrants or conversion of rights, as the warrants are not exercisable within 60 days of March 28, 2024 and the rights
are not convertible within 60 days of March 28, 2024.

 Name and Address of Beneficial Owner (1)

 Amount and
 Nature of
 Beneficial
 Ownership of
 Shares

 Approximate
 Percentage of
 Outstanding
 Shares

 Hooy Kok Wai (Our Sponsor) (2)

 3,614,500

 71.1
 %

 Chee Shiong (Keith) Kok

 160,000

 3.15
 %

 Shuk Man (Lora) Chan

 80,000

 1.57
 %

 Kym Hau

 5,000

 *

 Weiyi Di

 5,000

 *

 Tzu Fei (Philip) Ting

 5,000

 *

 All directors and executive officers as a group (5 individuals)

 255,000

 5.02
 %

 *

 Less
 than 1%.

 (1)

 Unless
 otherwise indicated, the business address of each of the individuals is c/o HHG Capital Corporation, 1 Commonwealth Lane, #03-20,
 Singapore, 149544.

 (2)

 Represents
 shares held by Mr. Kok Wai Hooy, our sponsor, whose address is 1 Commonwealth Lane, #03-20
 Singapore, 149544.

 ITEM
 13.

 CERTAIN
 RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 In
July 2020, 10,000 insider shares were issued to our initial subscriber of the Company. In November 2020, the initial subscriber transferred
the insider shares that it holds to HHG Investment Fund SPC – HHG Capital Fund SP ("HHG Fund"), and the Company further
issued 1,240,000 insider shares to HHG Fund and Forever Happiness Limited ("FHL"). In February 2021, the Company further
allotted 187,500 insider shares to HHG Fund, resulting in an aggregate of 1,437,500 ordinary shares outstanding, for an aggregate purchase
price of $25,000, or approximately $0.017 per share. In May 2021, HHG, FHL and all other shareholders transferred an aggregate of 1,437,500
insider shares to Expert Capital Investments Limited, who in turn transferred all 1,437,500 insider shares to Mr. Hooy Kok Wai (the "Sponsor")
in June 2021. At the end of June 2021, our Sponsor transferred an aggregate of 255,000 ordinary shares to the directors.

 Simultaneously
with the closing of the IPO, the Company consummated the private placement with certain of its initial shareholders of 255,000 units
at a price of $10.00 per Private Unit, generating total proceeds of $2,550,000.

 In
order to meet our working capital needs following the consummation of the IPO until completion of an initial business combination, our
initial shareholders, officers and directors or their affiliates may, but are not obligated to, loan us funds, from time to time or at
any time, in whatever amount they deem reasonable in their sole discretion. Each loan would be evidenced by a promissory note. The notes
would either be paid upon consummation of our initial business combination, without interest, or, at the lender's discretion, up
to $500,000 of the notes may be converted upon consummation of our business combination into private units at a price of $10.00 per unit
(which, for example, would result in the holders being issued units to acquire 50,000 ordinary shares, warrants to purchase 37,500 ordinary
shares and rights to receive 5,000 ordinary shares if $500,000 of notes were so converted). Our shareholders have approved the issuance
of the units and underlying securities upon conversion of such notes, to the extent the holder wishes to so convert them at the time
of the consummation of our initial business combination. If we do not complete a business combination, the loans would be repaid out
of funds not held in the trust account, and only to the extent available.

 The
holders of our insider shares issued and outstanding prior to the date of the IPO, as well as the holders of the private units (and all
underlying securities) and any securities our initial shareholders, officers, directors or their affiliates may be issued in payment
of working capital loans made to us, will be entitled to registration rights pursuant to offering registration rights agreement. The
holders of a majority of these securities are entitled to make up to two demands that we register such securities. The holders of the
majority of the insider shares can elect to exercise these registration rights at any time commencing three months prior to the date
on which these ordinary shares are to be released from escrow. The holders of a majority of the private units or securities issued in
payment of working capital loans made to us can elect to exercise these registration rights at any time after we consummate a business
combination. In addition, the holders have certain "piggy-back" registration rights with respect to registration statements
filed subsequent to our consummation of a business combination. We will bear the expenses incurred in connection with the filing of any
such registration statements.

 We
will reimburse our officers and directors for any reasonable out-of-pocket business expenses incurred by them in connection with certain
activities on our behalf such as identifying and investigating possible target businesses and business combinations. There is no limit
on the amount of out-of-pocket expenses reimbursable by us; provided, however, that to the extent such expenses exceed the available
proceeds not deposited in the trust account and the interest income earned on the amounts held in the trust account, such expenses would
not be reimbursed by us unless we consummate an initial business combination. Our audit committee will review and approve all reimbursements
and payments made to any initial shareholder or member of our management team, or our or their respective affiliates, and any reimbursements
and payments made to members of our audit committee will be reviewed and approved by our Board of Directors, with any interested director
abstaining from such review and approval.

 On
each of August 8, 2023, October 9, 2023 and November 17, 2023, the Company issued an unsecured promissory note to the Chief
Executive Officer, Mr. Chee
 Shiong (Keith) Kok, pursuant to which the Company may borrow up to an aggregate principal amount of $80,000, $100,000 and
$20,000 (the "Promissory Note"), respectively. The Promissory Note is non-interest bearing and payable upon consummation
of business combination. As of December 31, 2023 and 2022, the Chief
Executive Officer, Mr. Chee
 Shiong (Keith) Kok had advanced the Company an aggregate amount of $200,000 and
$0, respectively. The advances are non-interest bearing and due on demand.

 The
Sponsor and the Chief Executive Officer have paid the expenses incurred by the Company in aggregate of $60,000 on a non-interest
bearing basis as of December 31, 2023. As of December 31, 2023 and 2022, the Company owed an aggregate balance of $0 and $150,000 to
our Sponsor respectively.

 The
Company is obligated to pay Ms. Yeung Po Yi a monthly fee of $10,000 for general and administrative services. However, pursuant to the
terms of such agreement, the Company may delay payment of such monthly fee upon a determination by the Company's audit committee
that the Company lack sufficient funds held outside the trust to pay actual or anticipated expenses in connection with the initial business
combination. On September 4, 2023, both parties agreed to waive monthly fee of $10,000
commencing from July 1, 2023 and all the $210,000 outstanding balance as of June 30, 2023. The waiver of amount due to a related party of $210,000 was recorded in the consolidated statements of comprehensive
income during the year ended December 31, 2023.

 All
ongoing and future transactions between us and any of our officers and directors or their respective affiliates will be on terms believed
by us to be no less favorable to us than are available from unaffiliated third parties. Such transactions, including the payment of any
compensation, will require prior approval by a majority of our uninterested "independent" directors (to the extent we have
any) or the members of our board who do not have an interest in the transaction, in either case who had access, at our expense, to our
attorneys or independent legal counsel. We will not enter into any such transaction unless our disinterested "independent"
directors (or, if there are no "independent" directors, our disinterested directors) determine that the terms of such transaction
are no less favorable to us than those that would be available to us with respect to such a transaction from unaffiliated third parties.

 Related
Party Policy

 Our
Code of Ethics requires us to avoid, wherever possible, all related party transactions that could result in actual or potential conflicts
of interests, except under guidelines approved by the board of directors (or the audit committee). Related-party transactions are defined
as transactions in which (1) the aggregate amount involved will or may be expected to exceed $120,000 in any calendar year, (2) we or
any of our subsidiaries is a participant, and (3) any (a) executive officer, director or nominee for election as a director, (b) greater
than 5% beneficial owner of our ordinary shares, or (c) immediate family member, of the persons referred to in clauses (a) and (b), has
or will have a direct or indirect material interest (other than solely as a result of being a director or a less than 10% beneficial
owner of another entity). A conflict of interest situation can arise when a person takes actions or has interests that may make it difficult
to perform his or her work objectively and effectively. Conflicts of interest may also arise if a person, or a member of his or her family,
receives improper personal benefits as a result of his or her position.

 We
also require each of our directors and executive officers to annually complete a directors' and officers' questionnaire that
elicits information about related party transactions.

 Our
audit committee, pursuant to its written charter, will be responsible for reviewing and approving related-party transactions to the extent
we enter into such transactions. All ongoing and future transactions between us and any of our officers and directors or their respective
affiliates will be on terms believed by us to be no less favorable to us than are available from unaffiliated third parties. Such transactions
will require prior approval by our audit committee and a majority of our uninterested "independent" directors, or the members
of our board who do not have an interest in the transaction, in either case who had access, at our expense, to our attorneys or independent
legal counsel. We will not enter into any such transaction unless our audit committee and a majority of our disinterested "independent"
directors determine that the terms of such transaction are no less favorable to us than those that would be available to us with respect
to such a transaction from unaffiliated third parties. Additionally, we require each of our directors and executive officers to complete
a directors' and officers' questionnaire that elicits information about related party transactions.

 These
procedures are intended to determine whether any such related party transaction impairs the independence of a director or presents a
conflict of interest on the part of a director, employee or officer.

 To
further minimize potential conflicts of interest, we have agreed not to consummate a business combination with an entity which is affiliated
with any of our initial shareholders unless we obtain an opinion from an independent investment banking firm that the business combination
is fair to our unaffiliated shareholders from a financial point of view. Furthermore, in no event will any of our existing officers,
directors or initial shareholders, or any entity with which they are affiliated, be paid any finder's fee, consulting fee or other
compensation prior to, or for any services they render in order to effectuate, the consummation of a business combination.

Independence

 Nasdaq
listing standards require that a majority of our board of directors be independent. For a description of the director independence, see
above Part III, Item 10 - Directors, Executive Officers and Corporate Governance.

 ITEM
 14.

 PRINCIPAL
 ACCOUNTANT FEES AND SERVICES

 The
following is a summary of fees paid or to be paid to Marcum LLP ("Marcum") and Friedman LLP ("Friedman"),
for services rendered.

 Audit
Fees. Audit fees consist of fees billed for professional services rendered for the audits of our year-end financial statements and
services that are normally provided by the chosen registered public accounting firms in connection with regulatory filings. The aggregate fees billed by Friedman for professional services rendered
for the review of our quarterly financial statements totaled $10,000,
the aggregate
fees billed by Marcum for professional services rendered for the audit of our 2022 annual financial statements and review of our quarterly
financial statements totaled $51,805, and the aggregate fees billed by Marcum for professional services rendered for the
audit of our 2023 annual financial statements and review of our quarterly financial statements totaled $152,910. The above
amounts include interim procedures and audit fees, as well as attendance at audit committee meetings and professional services rendered
in connection with the IPO and the review of registration statement on Form F-4.

 Audit-Related
Fees. Audit-related services consist of fees billed for assurance and related services that are reasonably related to performance
of the audit or review of our financial statements and are not reported under "Audit Fees." These services include attest
services that are not required by statute or regulation and consultations concerning financial accounting and reporting standards. We
did not pay Friedman or Marcum for consultations concerning financial accounting and reporting standards during the years ended December
31, 2023 and 2022, respectively.

 Tax
Fees. We did not pay Friedman or Marcum for tax planning and tax advice for the years ended December 31, 2023 and 2022, respectively.

 All
Other Fees. We did not pay Friedman or Marcum for other services for the years ended December 31, 2023 and 2022, respectively.

 Pre-Approval
of Services

 Our
audit committee was formed upon the consummation of our IPO. Since the formation of our audit committee, and on a going-forward basis,
the audit committee has and will pre-approve all auditing services and permitted non-audit services to be performed for us by our auditors,
including the fees and terms thereof (subject to the de minimis exceptions for non-audit services described in the Exchange Act which
are approved by the audit committee prior to the completion of the audit).

 part
IV

 ITEM
 15.

 EXHIBITS
 AND FINANCIAL STATEMENT SCHEDULES

 (a)

 Financial
 Statements:

 (1)

 Financial
 Statements:

 Page

 Report of Independent Registered Public Accounting Firm

 Consolidated
 Balance Sheets

 Consolidated
 Statements of Comprehensive Loss

 Consolidated
 Statements of Changes in Shareholders' Deficit

 Consolidated
 Statements of Cash Flows

 Notes
 to Consolidated Financial Statements

 (2)

 All
 supplemental schedules have been omitted since the information is either included in the consolidated financial statements or the
 notes thereto or they are not required or are not applicable

 (3)

 See
 attached Exhibit Index of this Annual Report on Form 10-K

 (b)

 Exhibits

 EXHIBIT

 Exhibit
 No.

 Description

 1.1

 Underwriting Agreement, dated September 20, 2021, by and between the Registrant, EF Hutton, division of Benchmark Investments, LLC (incorporated by reference to Exhibit 1.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on September 23, 2021)

 2.1

 Merger Agreement dated August 2, 2023 by and between the Registrant, Purchaser, Merger Sub, and PHGL (incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed by the registrant with the Commission on August 4, 2023).

 3.1

 Amended and restated memorandum and articles of association of HHG Capital Corporation, dated September 21, 2023 (incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed by the registrant with the Commission on September 25, 2023).

 4.1

 Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 to the Registration Statement on Form S-1/A filed with the Securities & Exchange Commission on August 23, 2021)

 4.2

 Specimen Ordinary Share Certificate (incorporated by reference to Exhibit 4.2 to the Registration Statement on Form S-1/A filed with the Securities and Exchange Commission on March 16, 2021)

 4.3

 Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 to the Registration Statement on Form S-1/A filed with the Securities and Exchange Commission on August 23, 2021)

 4.4

 Specimen Right Certificate (incorporated by reference to Exhibit 4.4 to the Registration Statement on Form S-1/A filed with the Securities and Exchange Commission on August 23, 2021)

 4.5

 Warrant Agreement, dated September 20, 2021, by and between American Stock Transfer & Trust Company, LLC and the Registrant (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on September 23, 2021)

 4.6

 Rights Agreement, dated September 20, 2021, by and between American Stock Transfer & Trust Company, LLC and the Registrant (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on September 23, 2021)

 4.7

 Description of Securities (incorporated by reference to Exhibit 4.7 to the Annual Report on Form 10-K filed with the Securities & Exchange Commission on March 3, 2022)

 10.1

 Letter Agreement, dated September 20, 2021, by and between the Company and each of the officers and directors of the Company (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on September 23, 2021)

 10.2

 Letter Agreement, dated September 20, 2021, by and between the Company and the Sponsor (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on September 23, 2021)

 10.3

 Investment Management Trust Account Agreement, dated September 20, 2021, by and between American Stock Transfer & Trust Company, LLC and the Registrant (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on September 23, 2021)

 10.4

 Stock Escrow Agreement, dated September 20, 2021, among the Registrant, American Stock Transfer & Trust Company, LLC, and the initial shareholders (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on September 23, 2021)

 10.5

 Registration Rights Agreement, dated September 20, 2021, among the Registrant, American Stock Transfer & Trust Company, LLC and the initial shareholders (incorporated by reference to Exhibit 10.5 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on September 23, 2021)

 10.6

 Subscription Agreement, dated September 20, 2021, by and between the Company and the Sponsor (incorporated by reference to Exhibit 10.6 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on September 23, 2021)

 10.7

 Administrative Service Agreement, dated September 20, 2021, by and between the Company and Ms. Yeung Po Yi. (incorporated by reference to Exhibit 10.7 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on September 23, 2021)

 10.8

 Form of Indemnification Agreement, dated September 20, 2021, by and between the Company and each of the officers and directors of the Company (incorporated by reference to Exhibit 10.8 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on September 23, 2021)

 10.9

 Amendment to the investment management trust agreement, dated as of September 22, 2023, with Equiniti Trust Company LLC (formerly known as American Stock Transfer & Trust Company) (incorporated by reference to Exhibit 1.1 of the Current Report on Form 8-K filed by the registrant with the Commission on September 25, 2023).

 10.10

 Letter agreement (the "Letter Agreement") with Golden Eagle Brokerage Limited dated August 18, 2022 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on August 24, 2022)

 10.11

 Sponsor Support Agreement dated August 2, 2023 by and among HHGC and certain holders of HHGC ordinary shares (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed by the registrant with the Commission on August 4, 2023).

 10.12

 Form of Registration Rights Agreement (incorporated by reference to Exhibit 10.2 of the Current Report on Form 8-K filed by the registrant with the Commission on August 4, 2023)..

 10.13

 Form of Lock-Up Agreement (incorporated by reference to Exhibit 10.3 of the Current Report on Form 8-K filed by the registrant with the Commission on August 4, 2023)..

 Code of Ethics (incorporated by reference to Exhibit 14 to the Registration Statement on Form S-1 filed with the Securities & Exchange Commission on March 16, 2021)

 16.1

 Letter from Friedman LLP regarding the change in the Registrant's certifying accountant, dated September 21, 2022 (incorporated by reference to Exhibit 16.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on September 21, 2022)

 31.1

 Certification of Chief Executive Officer pursuant to Rule 13a-14 and Rule 15d-14(a), promulgated under the Securities and Exchange Act of 1934, as amended.

 31.2

 Certification of Chief Financial Officer pursuant to Rule 13a-14 and Rule 15d-14(a), promulgated under the Securities and Exchange Act of 1934, as amended.

 Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 97.1

 Clawback policy

 101.INS

 101.SCH

 101.CAL

 101.DEF

 101.LAB

 101.PRE

 Cover

 ITEM
 16.

 FORM
 10-K SUMMARY.

 None.

 SIGNATURES

to the requirements of Section 13 or 15(d) of the Exchange Act of 1934, the registrant caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.

 HHG

 Dated:

 By:

 /s/
 Chee Shiong (Keith) Kok

 Name:

 Chee
 Shiong (Keith) Kok

 Title:

 Chief
 Executive Officer

to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.

 Name

 Position

 Date

 /s/
 Chee Shiong (Keith) Kok

 Chief
 Executive Officer

 Chee
 Shiong (Keith) Kok

 (Principal
 executive officer) and Director

 /s/
 Shuk Man (Lora) Chan

 Chief
 Financial Officer

 Shuk
 Man (Lora) Chan

 (Principal
 financial and accounting officer) and Director

 /s/
 Kym Hau

 Kym
 Hau

 /s/
 Weiyi Di

 Weiyi
 Di

 /s/
 Tzu Fei (Philip) Ting

 Tzu
 Fei (Philip) Ting

 HHG

TO CONSOLIDATED FINANCIAL STATEMENTS

 Page

 Report of Independent Registered Public Accounting Firm (PCAOB ID: 688)

 Consolidated Balance Sheets

 Consolidated Statements of Comprehensive Income

 Consolidated Statements of Changes in Shareholders' Deficit

 Consolidated Statements of Cash Flows

 Notes to Consolidated Financial Statements

 – F-41

 F- 1

 REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 To
the Shareholders and Board of Directors of

 HHG
Capital Corporation

 Opinion
on the Financial Statements

 We
have audited the accompanying consolidated balance sheets of HHG Capital Corporation (the "Company") as of December 31, 2023
and 2022 the related consolidated statements of comprehensive income, changes in shareholders' deficit and cash flows for each
of the two years in the period ended December 31, 2023, and the related notes (collectively referred to as the "financial statements").
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2023 and 2022, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2023,
in conformity with accounting principles generally accepted in the United States of America.

 Restatement
of the 2022 Financial Statements

 As
discussed in Note 2 to the financial statements, the financial statements as of and for the year ended December 31, 2022 have been restated.

 Explanatory
Paragraph – Going Concern

 The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As described in Note
1 to the financial statements, the Company is a Special Purpose Acquisition Corporation that was formed for the purpose of acquiring,
engaging in a share exchange, share reconstruction and amalgamation, purchasing all or substantially all of the assets of, entering into
contractual arrangements, or engaging in any other similar business combination with one or more businesses or entities on or before
April 23, 2024 or discretion of the Board of Director accompanied by making additional contributions to the Trust Account to extend the
business combination deadline by an additional five months through September 23, 2024. The Company entered into a merger agreement with
a business combination target on August 2, 2023; however, the completion of this transaction is subject to the approval of the Company's
shareholders among other conditions. There is no assurance that the Company will obtain the necessary approvals, satisfy the required
closing conditions, raise the additional capital it needs to fund its operations, and complete the transaction prior to April 23, 2024,
if at all. The Company also has no approved plan in place to extend the business combination deadline and fund operations for any period
of time after April 23, 2024, in the event that it is unable to complete a business combination by that date. These matters raise
substantial doubt about the Company's ability to continue as a going concern. Management's plans with regard to these matters
are also described in Note 1. The financial statements do not include any adjustments that may be necessary should the Company be unable
to continue as a going concern.

 Basis
for Opinion

 These
financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

 Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits
provide a reasonable basis for our opinion.

 /s/
Marcum llp

 Marcum
 llp

 Marcum
LLP

 We
have served as the Company's auditor since 2020 (such date takes into account the acquisition of certain assets of Friedman LLP
by Marcum LLP effective September 1, 2022).

 Costa
Mesa, CA

 April
1, 2024

 F- 2

 HHG

 CONSOLIDATED
BALANCE SHEETS

 ASSETS

 Cash

 $
 16,014

 $

 12,672

 6,025

 Total current assets

 28,686

 334,894

 Non-current assets:

 TOTAL ASSETS

 $
 35,938,337

 $

 LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS' DEFICIT

 $
 124,350

 $
 36,307

 -

 150,000

 Promissory note – related party

 200,000

 -

 Total current liabilities

 324,350

 186,307

 Deferred underwriting compensation

 TOTAL LIABILITIES

 1,939,350

 1,801,307

 Commitments and contingencies

 -

 -

 Ordinary shares subject to possible redemption: 3,323,561 and 3,356,406 shares issued and outstanding at redemption value at December 31, 2023 and 2022, respectively

 Shareholders' deficit:

 Ordinary shares, $ 0.0001 par value; 500,000,000 shares authorized; 1,727,000 shares issued and outstanding (excluding 3,323,561 and 3,356,406 shares subject to redemption) at December 31, 2023 and 2022, respectively

 ( 1,910,836
)

)

 Total shareholders' deficit

 ( 1,910,664
)

)

 TOTAL LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS' DEFICIT

 $
 35,938,337

 $

 See
accompanying notes to consolidated financial statements.

 F- 3

 HHG

 CONSOLIDATED
STATEMENTS OF COMPREHENSIVE INCOME

 Year ended December 31, 2023

 Year ended December 31, 2022

 $
 ( 553,141
)

 $
 ( 553,943
)

 1,712,250

 616,543

 3,472

 Waiver of amount due to a related party

 -

 1,925,722

 617,150

 NET INCOME

 $

 $

 Other comprehensive loss:

 Unrealized gain on available-for-sale securities

 -

 Reclassification of realized gain on available-for-sale securities, net to net income

 -

)

 COMPREHENSIVE INCOME

 $

 $
 62,883

 Basic and diluted weighted average shares outstanding, ordinary shares subject to possible redemption

 3,347,407

 5,087,663

 Basic and diluted net income per ordinary shares subject to possible redemption

 $
 0.46

 $
 0.48

 Basic and diluted weighted average shares outstanding, non-redeemable ordinary share

 Basic and diluted net loss per non-redeemable ordinary share

 $
 ( 0.09
)

 $
 ( 1.39
)

 See
accompanying notes to consolidated financial statements.

 F- 4

 HHG

 CONSOLIDATED
STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT

 No. of shares

 paid-in

 capital

 comprehensive

 shareholders' deficit

 Year ended December 31, 2023

 Ordinary shares

 Additional

 Accumulated

 other

 Total

 No. of shares

 paid-in

 capital

 comprehensive

 shareholders' deficit

 Balance as of January 1, 2023 (As restated)

 $

 $
 -

 $
 -

 $
)

 $
)

 -

 -

 -

 -

 ( 1,816,832
)

 ( 1,816,832
)

 Net income for the year

 -

 -

 -

 -

 Balance as of December 31, 2023

 $

 $
 -

 $
 -

 $
 ( 1,910,836
)

 $
 ( 1,910,664
)

 Year ended December 31, 2022

 Ordinary shares

 Additional

 Accumulated

 other

 Total

 shareholders'

 No. of shares

 paid-in

 capital

 comprehensive

 Accumulated

 deficit

 equity

 (deficit)

 Balance as of January 1, 2022

 $

 $
 8,164,707

 $

 $
 ( 158,774
)

 $
 8,006,429

 Balance

 $

 $
 8,164,707

 $

 $
 ( 158,774
)

 $
 8,006,429

 -

 -

 ( 8,164,707
)

 -

 ( 1,371,018
)

 ( 9,535,725
)

 Unrealized holding gain on available-for-sales securities

 -

 -

 -

 -

 Reclassification of realized gain on available-for-sale securities, net to net income

 -

 -

 -

)

 -

)

 Net income for the year

 -

 -

 -

 -

 Balance as of December 31, 2022 (as restated)

 $

 $
 -

 $
 -

 $
)

 $
)

 Balance

 $

 $
 -

 $
 -

 $
)

 $
)

 See
accompanying notes to consolidated financial statements.

 F- 5

 HHG

 CONSOLIDATED
STATEMENTS OF CASH FLOWS

 Year ended December 31, 2023

 Year ended December 31, 2022

 Cash flows from operating activities:

 $

 $

 Adjustments to reconcile net income to net cash used in operating activities

 ( 1,712,250
)

 ( 616,543
)

 Waiver of amount due to a related party

 ( 210,000
)

 -

 Change in operating assets and liabilities

 Increase in prepayment

 ( 6,647
)

 ( 1,941
)

 Increase in accrual and other payable

 88,043

 21,049

 120,000

 ( 408,273
)

 ( 414,228
)

 Cash flows from investing activities:

 Proceeds of extension payments deposited in Trust Account

 ( 104,582
)

 ( 36,321
)

 Withdraw of investments in Trust Account for redemption of ordinary shares

 361,224

 24,274,780

 Net cash provided by investing activities

 256,642

 24,238,459

 Cash flows from financing activities:

 Proceeds from issuance of promissory notes

 200,000

 -

 Repayment to a related party

 -

 ( 450
)

 Redemption of ordinary shares

)

 ( 24,274,780
)

 Net cash used in financing activities

 ( 161,224
)

 ( 24,275,230
)

 NET CHANGE IN CASH

 ( 312,855
)

 ( 450,999
)

 CASH, BEGINNING OF YEAR

 779,868

 CASH, END OF YEAR

 16,014

 $

 SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:

 $
 ( 1,816,832
)

 $
 ( 9,535,725
)

 See
accompanying notes to consolidated financial statements.

 F- 6

 HHG

 NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

 NOTE
1 – ORGANIZATION AND BUSINESS BACKGROUND

 HHG
Capital Corporation (the "Company" or "we", "us" and "our") is a newly organized blank
check company incorporated on July 15, 2020, under the laws of the British Virgin Islands for the purpose of acquiring, engaging in a
share exchange, share reconstruction and amalgamation, purchasing all or substantially all of the assets of, entering into contractual
arrangements, or engaging in any other similar business combination with one or more businesses or entities ("Business Combination").
Currently, the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination,
except for any entity with its principal business operations in China (including Hong Kong).

 As
of December 31, 2023, the Company had not commenced any operations. The Company's entire activities from inception up to September
23, 2021 relate to the Company's formation and the Initial Public Offering as described below. Since the Initial Public Offering,
the Company's activity has been limited to the evaluation of business combination candidates. The Company has selected December
31 as its fiscal year end.

 Financing

 The
registration statement for the Company's Initial Public Offering (the "Initial Public Offering" or "IPO"
as described in Note 5) became effective on September 20, 2021. On September 23, 2021, the Company consummated the Initial Public Offering
of 5,000,000 ordinary units (the "Public Units"), generating gross proceeds of $ 50,000,000 which is described in Note 5.

 Simultaneously,
the underwriters exercised the over-allotment option in full. The underwriters purchased an additional 750,000 Units (the "Over-Allotment
Units") at an offering price of $ 10.00 per Unit, generating gross proceeds to the Company of $ 7,500,000.

 Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of 237,000 units (the "Private Units")
at a price of $ 10.00 per Private Unit in a private placement, generating gross proceeds of $ 2,370,000, which is described in Note 6.
On September 23, 2021, simultaneously with the sale of the over-allotment units, the Company consummated the private sale of an additional
 18,000 Private Units, generating gross proceeds of $ 180,000.

 Transaction
costs paid upon the consummation of the Initial Public Offering amounted to $ 1,031,411, consisting of $ 805,000 of underwriter's
fees and $ 226,411 of other offering costs.

 F- 7

 Trust
Account

 Upon
the closing of the Initial Public Offering, the exercise of the over-allotment option and the closing of the private placement, $ 58,075,000
was placed in a trust account (the "Trust Account") with American Stock & Trust Company, LLC acting as trustee. The funds
held in the Trust Account can be invested in United States government treasury bills, bonds or notes, having a maturity of 180 days or
less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act until the earlier
of (i) the consummation of the Company's initial Business Combination and (ii) the Company's failure to consummate a Business
Combination within the Combination Period as described below. Placing funds in the Trust Account may not protect those funds from third
party claims against the Company. Although the Company will seek to have all vendors, service providers, prospective target businesses
or other entities it engages, execute agreements with the Company waiving any claim of any kind in or to any monies held in the Trust
Account, there is no guarantee that such persons will execute such agreements. The remaining net proceeds (not held in the Trust Account)
may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative
expenses. Additionally, the dividend earned on the Trust Account balance may be released to the Company to pay the Company's tax
obligations. On September 19, 2022, upon the Company's shareholders approval of the Charter Amendment, 2,393,594 shares were redeemed
by certain shareholders at a price of approximately $ 10.12 per share, including dividend generated in the Trust Account, in an aggregate
amount of $ 24,223,171. On December 1, 2022, the aggregate amount adjusted to $ 24,274,780. On September 25, 2023, upon the Company's
shareholders approval of the Charter Amendment II, 32,845 shares were redeemed by certain shareholders at a price of approximately $ 11.00
per share, including dividend generated in the Trust Account, in an aggregate amount of $ 361,224.

 Business
Combination

to Nasdaq listing rules, the Company's initial Business Combination must occur with one or more target businesses having an aggregate
fair market value equal to at least 80% of the value of the funds in the Trust Account (excluding any deferred underwriter's fees
and taxes payable on the income earned on the Trust Account), which the Company refers to as the 80% test, at the time of the execution
of a definitive agreement for the initial Business Combination, although the Company may structure a Business Combination with one or
more target businesses whose fair market value significantly exceeds 80% of the Trust Account balance. If the Company is no longer listed
on Nasdaq, it will not be required to satisfy the 80% test. The Company currently anticipates structuring a Business Combination to acquire
 100 % of the equity interests or assets of the target business or businesses.

 The
Company will provide its shareholders with the opportunity to redeem all or a portion of their ordinary shares obtained in the Initial
Public Offering ("Public Shares") upon the completion of a Business Combination either (i) in connection with a shareholder
meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek
shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The shareholders
will be entitled to redeem their Public Shares for a pro rata portion of the amount then on deposit in the Trust Account (initially $ 10.10
per share, plus any pro rata dividend earned on the funds held in the Trust Account and not previously released to the Company to pay
its tax obligations). The per-share amount to be distributed to shareholders who redeem their shares will not be reduced by the deferred
underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). There will be no redemption rights upon the
completion of a Business Combination with respect to the Company's warrants and rights. The ordinary shares subject to redemption
was initially recorded at its fair value at the date of issuance and classified as temporary equity upon the completion of the Initial
Public Offering, in accordance with Accounting Standards Codification ("ASC") Topic 480 "Distinguishing Liabilities
from Equity."

 The
Company will proceed with a Business Combination if the Company has net tangible assets of at least $ 5,000,001 upon such consummation
of a Business Combination and, if the Company seeks shareholder approval, a majority of the outstanding shares voted are voted in favor
of the Business Combination. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business
or other legal reasons, the Company will, pursuant to its Second Amended and Restated Memorandum and Articles of Association, offer such
redemption pursuant to the tender offer rules of the Securities and Exchange Commission ("SEC"), and file tender offer documents
containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.

 F- 8

 The
Company's initial shareholders (the "initial shareholders") have agreed (a) to vote their insider shares, the ordinary
shares included in the Private Units (the "Private Shares") and any Public Shares purchased during or after the Initial Public
Offering in favor of a Business Combination, (b) not to propose, or vote in favor of, an amendment to the Company's Second Amended
and Restated Memorandum and Articles of Association that would stop the public shareholders from converting or selling their shares to
the Company in connection with a Business Combination or affect the substance or timing of the Company's obligation to redeem 100%
of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) unless
the Company provides dissenting public shareholders with the opportunity to convert their Public Shares into the right to receive cash
from the Trust Account in connection with any such vote; (c) not to convert any insider shares and Private Units (including underlying
securities) (as well as any Public Shares purchased during or after the Initial Public Offering) into the right to receive cash from
the Trust Account in connection with a shareholder vote to approve a Business Combination (or sell any shares in a tender offer in connection
with a Business Combination) or a vote to amend the provisions of the Second Amended and Restated Memorandum and Articles of Association
relating to shareholders' rights of pre-Business Combination activity and (d) that the insider shares and Private Units (including
underlying securities) shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated.
However, the initial shareholders will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares
purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. The Company will have
until 31 months (or up to 36 months if the Company extends the period of time to consummate a business combination, as described in more
detail below) from the closing of the Initial Public Offering to complete its Business Combination (the "Combination Period").

 On
August 17, 2022, the Company has reached an agreement (the "Waiver Agreement") with Kok Wai Hooy ("Sponsor"),
who is its largest public shareholder, and with certain other holders of Public Shares (the "Anchor Shareholders") who, as
of August 17, 2022, together own 3,084,000 Public Shares, which represent 53.63 % of all outstanding Ordinary Shares that are owned by
its public shareholders. Pursuant to the Waiver Agreement, the Anchor Shareholders have agreed to waive their pro rata share of all Extension
Payments made into the Trust Account after the date thereof. As a result, each monthly Extension Payment (of $ 88,867 if there are no
redemptions) that is paid into the Trust Account would be segregated so that only the Company's public shareholders who have not
redeemed their Shares, excluding the Anchor Shareholders, would receive their pro rata share of each such monthly extension payment (in
addition to their pro rata share of amounts then in the Trust Account) upon redemption or upon the liquidation of the Company as provided
in its amended charter after giving effect to the Charter Amendment (as described below). The Waiver Agreement also provides that the
Anchor Shareholders will agree not to sell or otherwise transfer any of their Shares (subject to customary exceptions for transfers to
certain family members and other affiliates) other than in connection with a redemption of their Shares in the event that the Company
is forced to dissolve or liquidate. The terms of the Waiver Agreement, when taken together with the Charter Amendment and the Trust Amendment,
would place all of its shareholders (other than the Anchor Shareholders) in the same financial position that they would have been if
each monthly extension payment was equal to one-third of the payment for each three-month extension provided for under its previous charter.

 On
September 19, 2022, the shareholders of the Company approved an amended and restated memorandum and articles of association (the "Charter
Amendment"), giving the Company the right to extend the date by which it has to complete a business combination up to twelve (12)
times for an additional one (1) month each time, from September 23, 2022 up to September 23, 2023. Additionally, the Charter Amendment
also allowed the holders of the Public Shares to redeem the shares when the Directors of the Company propose any amendment to the Company's
amended and restated memorandum and article of association that would affect the substance or timing of the redemption of the Public
Shares. Accordingly, on September 19, 2022, 2,393,594 Public Shares were redeemed for the pro-rata share of the deposits then in the
Trust Account.

 Along
with the Company's amendment to the amended and restated memorandum and article of association, the Company entered into an amendment
(the "Trust Amendment") to the investment management trust agreement, dated as of September 19, 2021, with American Stock
Transfer & Trust Company. Pursuant to the Trust Amendment, the Company has the right to extend the time to complete a business combination
twelve (12) times for an additional one (1) month each time from September 23, 2022, up to September 23, 2023, by depositing $ 0.033 for
each issued and outstanding Public Shares for each one-month extension, excluding Public Shares hold by the Anchor Shareholders.

 F- 9

 On
September 21, 2023, the shareholders of the Company approved an amended and restated memorandum and articles of association (the "Charter
Amendment II"), giving the Company the right to extend the date by which it has to complete a business combination up to twelve
(12) times for an additional one (1) month each time, from September 23, 2023 to up to September 23, 2024. Additionally, the Charter
Amendment II also allowed the holders of the Public Shares to redeem the shares when the Directors of the Company propose any amendment
to the Company's amended and restated memorandum and article of association that would affect the substance or timing of the redemption
of the Public Shares. Accordingly, on September 22, 2023, 32,845 Public Shares were redeemed for the pro-rata share of the deposits then
in the Trust Account.

 Along
with the Company's amendment to the amended and restated memorandum and article of association, the Company entered into an amendment
(the "Trust Amendment II") to the investment management trust agreement, dated as of September 19, 2021, with Equiniti Trust
Company LLC (formerly known as American Stock Transfer & Trust Company). Pursuant to the Trust Amendment II, the Company has the
right to extend the time to complete a business combination twelve (12) times for an additional one (1) month each time from September
23, 2023, to September 23, 2024, by depositing $ 0.0333 for each issued and outstanding Company's ordinary share issued in the IPO that
has not been redeemed held by shareholders who did not enter into the Waiver Agreement (each, a "non-waiving Public Share")
or each one-month extension. Non-waiving Public Shares are the shares held by the shareholders holding
public shares but did not enter the "Waiver Agreement" and are entitled to receive the monthly Extension Payments which the
Company deposits into the Trust Fund.

 The
Company was using part of proceeds from promissory note – related party which deposited into the Trust Account in order to
extend the amount of available time to complete a business combination. On each of September 21, 2022, October 31, 2022, November
28, 2022, December 21, 2022, January 20, 2023, February 21, 2023, March 21, 2023, April 21, 2023, May 23, 2023, June 23, 2023 and
July 23, 2023, the Company had deposited $ 9,080
into the Trust Account in order to extend the amount of available time to complete a business combination until August 23, 2023. On
each of August 23, 2023, September 23, 2023, October 20, 2023, November 22, 2023, December 22, 2023, January 23, 2024,
February 23, 2024 and March 20, 2024, the Company had deposited $ 7,985
into the Trust Account in order to extend the amount of available time to complete a business combination until April
23, 2024.

 On
March 15, 2023, the Company has entered into non-binding letter of intent with Perfect Hexagon Group Limited.

 On
August 2, 2023, the Company entered into an agreement and plan of merger (the "Merger Agreement") with Perfect Hexagon Holdings
Limited, a British Virgin Islands business company and wholly owned subsidiary of the Company ("Purchaser"), Perfect Acquisitions
Limited, a British Virgin Islands business company and wholly owned subsidiary of Purchaser ("Merger Sub"), and Perfect Hexagon
Group Limited, a British Virgin Islands business company ("Perfect Hexagon"). Upon the closing of the transactions contemplated
by the Merger Agreement, (a) the Company will be merged with and into Purchaser (the "Reincorporation Merger"), with Purchaser
surviving the Reincorporation Merger, and (b) Merger Sub will be merged with and into Perfect Hexagon (the "Acquisition Merger"),
with Perfect Hexagon surviving the Acquisition Merger as a direct wholly owned subsidiary of Purchaser (collectively, the "Merger"
or the "Business Combination"). Following the Business Combination, Purchaser will be a publicly traded company listed on
a stock exchange in the United States. Pursuant to the terms of the Merger Agreement, the aggregate consideration to be paid at the closing
of the Business Combination to existing shareholders of the Investor is $ 990,000,000
 (the "Merger Consideration"), which
will be paid in 99,000,000
 newly issued ordinary shares of the Purchaser at a deemed price of $ 10.00
 per share.

 Liquidation

 If
the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except
for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem 100 % of
the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account,
including dividend earned (net of taxes payable), which redemption will completely extinguish public shareholders' rights as shareholders
(including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of the remaining shareholders and the Company's board of directors,
proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations
to provide for claims of creditors and the requirements of applicable law. The underwriters have agreed to waive its rights to the deferred
underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination
Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the
redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available
for distribution will be less than $ 10.10 as initially deposited in the Trust Account.

 F- 10

 The
Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products
sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce
the amounts in the Trust Account to below $ 10.10 per share (whether or not the underwriters' over-allotment option is exercised
in full), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and
except as to any claims under the Company's indemnity of the underwriters of the Initial Public Offering against certain liabilities,
including liabilities under the Securities Act of 1933, as amended (the "Securities Act"). In the event that an executed
waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such
third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to
claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which
the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies
held in the Trust Account.

and going concern

 For
the year ended December 31, 2023, the Company generated net income of $ 1,372,581 but had cash used in operating activities of $ 408,273.
As of December 31, 2023, the Company had cash of $ 16,014 and working capital deficit of $ 295,664. Until the consummation of a Business
Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition
candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business
to acquire, and structuring, negotiating and consummating the Business Combination. The Company may need to raise additional capital
through loans or additional investments from its Sponsor or third parties as discussed in Note 7.

 In
connection with the Company's assessment of going concern in accordance with the authoritative guidance in ASU 2014-15,
"Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern," management has concluded
that the Company has incurred net cash used in operating activities and determined that the mandatory liquidation and subsequent
dissolution, should the Company be unable to raise additional funds to meet its obligations and complete a Business Combination,
raises substantial doubt about the Company's ability to continue as a going concern. The Company has until April
23, 2023 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by
this time. If a Business Combination is not consummated by this date without an extension to the acquisition period, there will be a
mandatory liquidation and subsequent dissolution. No adjustments have been made to the carrying amounts of assets or liabilities
should the Company be required to liquidate after Se pte mber 23, 2024. Pursuant to the
Trust Amendment II, the Company has the right to extend the time to complete a business combination twelve (12) times for an
additional one (1) month each time from September 23, 2023, to September 23, 2024, by depositing $ 0.0333
for each issued and outstanding Company's ordinary share issued in the IPO that has not been redeemed held by shareholders who
did not enter into the Waiver Agreement or each one-month extension.

 Accordingly,
the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required
to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations,
suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new
financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the
Company's ability to continue as a going concern through one year from the date of these consolidated financial statements if
a Business Combination is not consummated. These consolidated financial statements do not include any
adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should
the Company be unable to continue as a going concern.

 NOTE
2 – RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

 In
connection with the preparation of the Company's consolidated financial statements as of December 31, 2023, management
determined it should restate its previously reported consolidated financial statements as of and for the year ended December 31,
2022, and unaudited condensed consolidated financial statements as of and for the periods ended March 31, 2023, June 30, 2023, and
September 30, 2023. During the preparation of this Annual Report on Form 10-K, the Company determined that it had not appropriately
accounted for interest earned on investments held in Trust Account under accounting principles generally accepted in the United
States of America ("U.S. GAAP"). Interest income was recorded based on actual cash receipts instead of on an accrual
basis resulting in an understatement of Investments held in Trust Account in prior periods. Additionally, the interest earned on
investments held in Trust Account, net income and ordinary shares subject to possible redemption were misstated. In preparing the
consolidated statement of cash flows, the Company identified an additional error related to the classification of administrative
service cash flow. The Company determined that amount due to a related party arising from unpaid administrative service fees was
incorrectly classified under financing activities instead of a reconciliation item to operating activities. As a result of the
restatement, the Company's amount due to related party of $ 120,000
in audited consolidated statements of cash flows for the year ended December 31, 2022, $ 30,000
and $ 60,000
in unaudited condensed consolidated statements of cash flows for the three months and six months ended March 31, 2023 and June 30,
2023 were reclassified to operating activities.

 In
accordance with Staff Accounting Bulletin ("SAB") 99, "Materiality", and SAB 108, "Considering the
Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements", the Company
evaluated the materiality of the errors from qualitative and quantitative perspectives, individually and in aggregate, and concluded
that the errors were material to the consolidated financial statements for the fiscal year ended December 31, 2022, and the quarters
ended March 31, 2023, June 30, 2023, and September 30, 2023.

 The
relevant unaudited consolidated interim
financial information for the quarterly periods ended March 30, 2023, June 30, 2023, and September 30, 2023, are included in Note 11,
Quarterly Financial Information (Unaudited). The categories of misstatements and their impact on the previously issued financial statements
are described in more detail in the tables below.

 F- 11

 Description
of Restatement Tables

 SCHEDULE
OF IMPACT OF REVISION IN FINANCIAL STATEMENTS

 The
impact of the revision on the Company's financial statements is reflected in the following table:

 As

 Adjustment

 As

 Audited
 Consolidated Balance Sheet as of December 31, 2022

 $
 34,344,102

 $

 $

 Total assets

 $
 34,678,996

 $

 $

 $
 34,344,102

 $

 $

 Consolidated Balance Sheet as of March 31, 2023

 $
 34,714,871

 $

 $

 Total assets

 $
 34,969,651

 $

 $

 $
 34,714,871

 $

 $

 Consolidated Balance Sheet as of June 30, 2023

 $
 35,143,815

 $

 $

 Total assets

 $
 35,222,504

 $

 $

 $
 35,143,815

 $

 $

 Consolidated Balance Sheet as of September 30, 2023

 $
 35,262,118

 $

 $

 Total assets

 $
 35,287,920

 $

 $

 $
 35,262,118

 $

 $

 Audited
 Statement of Comprehensive Loss for the year ended December 31, 2022

 $
 506,602

 $

 $
 616,543

 Basic and diluted net income
 per share, ordinary shares subject to possible redemption

 $
 0.46

 $
 0.02

 $
 0.48

 Consolidated Statement of Comprehensive Income (Loss) for the three months ended March 31, 2023

 $
 343,529

 $

 $
 365,731

 diluted net income per share, ordinary shares subject to possible redemption

 $
 0.09

 $
 0.01

 $
 0.10

 Consolidated Statement of Comprehensive Income (Loss) for the three months ended June 30, 2023

 $
 401,703

 $

 $
 415,654

 diluted net income per share, ordinary shares subject to possible redemption

 $
 0.08

 $
 0.01

 $
 0.09

 Consolidated Statement of Comprehensive Income (Loss) for the six months ended June 30, 2023

 $
 745,232

 $

 $
 781,385

 diluted net income per share, ordinary shares subject to possible redemption

 $
 0.17

 $
 0.01

 $
 0.18

 Consolidated Statement of Comprehensive Income (Loss) for the three months ended September 30, 2023

 Dividend income earned in
 investments held in Trust Account

 $
 453,381

 $
 6,216

 $
 459,597

 Consolidated Statement of Comprehensive Income (Loss) for the nine months ended September 30, 2023

 $
 1,198,613

 $

 $
 1,240,982

 diluted net income per share, ordinary shares subject to possible redemption

 $
 0.32

 $
 0.01

 $
 0.33

 Audited
 Consolidated Statement of Changes in Shareholders' Deficit for the year ended December 31, 2022

 Accretion of carrying value to redemption value
 of redeemable ordinary shares

 $
 ( 9,425,784
)

 $
)

 $
 (9,535,725
)

 Net
 (loss) income for the year

 $
 ( 46,734
)

 $

 $

 Consolidated Statement of Changes in Shareholders' Deficit for the three months ended March 31, 2023

 to redemption value of redeemable ordinary shares

 $
 ( 370,769
)

 $
 ( 22,202
)

 $
 (392,971
)

 $

 $

 $

 Consolidated Statement of Changes in Shareholders' Deficit for the three months ended June 30, 2023

 to redemption value of redeemable ordinary shares

 $
 ( 428,944
)

 $
 ( 13,951
)

 $
 (442,895
)

 $
 197,988

 $

 $
 211,939

 Consolidated Statement of Changes in Shareholders' Deficit for the six months ended June 30, 2023

 to redemption value of redeemable ordinary shares

 $
 ( 799,713
)

 $
 ( 36,153
)

 $
 (835,866
)

 $
 462,279

 $

 $

 Consolidated Statement of Changes in Shareholders' Deficit for the three months ended September 30, 2023

 $
 ( 479,527
)

 $
 ( 6,216
)

 $
 (485,743
)

 $
 491,951

 $
 6,216

 $
 498,167

 Consolidated Statement of Changes in Shareholders' Deficit for the nine months ended September 30, 2023

 $
 ( 1,279,240
)

 $
)

 $
 (1,321,609
)

 $
 954,230

 $

 $

 Audited
 Consolidated Statement of Cash Flows for the year ended December 31, 2022

 (loss)

 $
 ( 46,734
)

 $

 $

 $
 ( 506,602
)

 $
)

 $
 (616,543
)

 $
 ( 9,425,784
)

 $
)

 $
 (9,535,725
)

 Condensed Consolidated Statement of Cash Flows for the three months ended March 31, 2023

 $

 $

 $

 $
 ( 343,529
)

 ( 22,202
)

 (365,731
)

 $
 370,769

 $

 $
 392,971

 Condensed Consolidated Statement of Cash Flows for the six months ended June 30, 2023

 $
 462,279

 $

 $

 $
 ( 745,232
)

 ( 36,153
)

 (781,385
)

 $
 799,713

 $

 $
 835,866

 Condensed Consolidated Statement of Cash Flows for the nine months ended September 30, 2023

 $
 954,230

 $

 $

 $
 ( 1,198,613
)

)

 (1,240,982
)

 $
 ( 1,279,240
)

 $
)

 $
 (1,321,609
)

 F- 12

 SCHEDULE OF RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

 HHG

CONSOLIDATED BALANCE SHEET

 (AUDITED)

 December
31, 2022

 Cash

 $

 $
 —

 $

 6,025

 —

 6,025

 Total Current Assets

 334,894

 —

 334,894

 34,344,102

 Total Assets

 $
 34,678,996

 $

 $

 $
 36,307

 $
 —

 $
 36,307

 150,000

 —

 150,000

 Promissory note - related party

 Total Current Liabilities

 186,307

 —

 186,307

 Deferred underwriting fee payable

 —

 Total Liabilities

 1,801,307

 —

 1,801,307

 Commitments and Contingencies

 -

 -

 -

 Ordinary shares subject to possible redemption, 3,356,406 and 5,750,000 shares issued and outstanding at redemption value

 34,344,102

 Ordinary shares, $ 0.0001 par value; 500,000,000 shares authorized; 1,727,000 shares issued and outstanding (excluding 3,356,406 shares subject to redemption)

 —

)

 —

)

 Total Stockholders' Deficit

)

 —

)

 Total Liabilities, Temporary Equity, and Stockholders' Deficit

 $
 34,678,996

 $

 $

 F- 13

 HHG

 (AUDITED)

 For the Year Ended

 $
 ( 553,943
)

 $
 —

 $
 ( 553,943
)

 Dividend income earned in investments held in Trust
 Account

 506,602

 616,543

 —

 Other income

 507,209

 617,150

 Net (loss) income

 $
 ( 46,734
)

 $

 $

 Other comprehensive loss:

 Unrealized gain on available-for-sale securities

 —

 Reclassification of realized gain on available-for-sale securities, net to net income

)

 —

)

 Comprehensive income (loss)

 $
 ( 47,058
)

 $

 $
 62,883

 Basic and diluted weighted average shares outstanding, common stock subject to possible redemption

 5,087,663

 —

 5,087,663

 Basic and diluted net income per share, common stock subject to possible redemption

 $
 0.46

 $
 0.02

 $
 0.48

 Basic and diluted weighted average shares outstanding, non-redeemable common stock

 —

 $
 ( 1.39
)

 $
 —

 $
 ( 1.39
)

 F- 14

 HHG

STATEMENT OF CASH FLOWS

 (AUDITED)

 For the Year Ended

 Cash Flows from Operating Activities:

 Net (loss) income

 $
 ( 46,734
)

 $

 $

 Adjustments to reconcile net income (loss) to net cash used in operating activities:

 ( 506,602
)

)

 ( 616,543
)

 Waiver of amount due to a related party

 Changes in operating assets and liabilities:

 Increase in prepayment

 ( 1,941
)

 —

 ( 1,941
)

 Increase in accrual and other payable

 21,049

 —

 21,049

 —

 120,000

 120,000

 ( 534,228
)

 120,000

 ( 414,228
)

 Cash Flows from Investing Activities:

 Withdraw of investment in Trust Account

 24,274,780

 —

 24,274,780

 Proceeds deposited in Trust Account

 ( 36,321
)

 ( 36,321
)

 Net cash provided by investing activities

 24,238,459

 —

 24,238,459

 Cash Flows from Financing Activities:

 Common stock redemption

 ( 24,274,780
)

 —

 ( 24,274,780
)

 Repayment to a related party

 119,550

 ( 120,000
)

 ( 450
)

 Proceeds from issuance of promissory note

 Net cash used in financing activities

 ( 24,155,230
)

 ( 120,000

)

 ( 24,275,230
)

 Net Change in Cash

 ( 450,999
)

 —

 ( 450,999
)

 Cash, Beginning of the Year

 779,868

 —

 779,868

 Cash, End of the Year

 $

 $
 —

 $

 Supplemental Disclosure of Non-cash Financing Activities

 $
 ( 9,425,784
)

 $
)

 $
 ( 9,535,725
)

 F- 15

 HHG

UNAUDITED CONSOLIDATED BALANCE SHEET

 March
31, 2023

 Cash

 $

 $
 —

 $

 60,853

 —

 60,853

 Total Current Assets

 254,780

 —

 254,780

 34,714,871

 Total Assets

 $
 34,969,651

 $

 $

 $
 32,671

 $
 —

 $
 32,671

 180,000

 —

 180,000

 Total Current Liabilities

 212,671

 —

 212,671

 Deferred underwriting fee payable

 —

 Total Liabilities

 1,827,671

 —

 1,827,671

 Commitments and Contingencies

 -

 -

 -

 Ordinary shares subject to possible redemption, 3,356,406 shares issued and outstanding at redemption value

 34,714,871

 Ordinary shares, $ 0.0001 par value; 500,000,000 shares authorized; 1,727,000 shares issued and outstanding (excluding 3,356,406 shares subject to redemption)

 —

 ( 1,573,063
)

 —

 ( 1,573,063
)

 Total Stockholders' Deficit

 ( 1,572,891
)

 —

 ( 1,572,891
)

 Total Liabilities, Temporary Equity, and Stockholders' Deficit

 $
 34,969,651

 $

 $

 F- 16

 HHG

 Three Months Ended

 $
 ( 82,045
)

 $
 —

 $
 ( 82,045
)

 343,529

 365,731

 2,807

 —

 2,807

 346,336

 368,538

 $

 $

 $

 Other comprehensive loss:

 Unrealized gain on available-for-sale securities

 —

 —

 —

 Reclassification of realized gain on available-for-sale securities, net to net income

 —

 —

 —

 Comprehensive income

 Basic and diluted weighted average shares outstanding, common stock subject to possible redemption

 —

 Basic and diluted net income per share, common stock subject to possible redemption

 $
 0.09

 $
 0.01

 $
 0.10

 Basic and diluted weighted average shares outstanding, non-redeemable common stock

 —

 $
 ( 0.02
)

 $
 —

 $
 ( 0.02
)

 F- 17

 HHG

UNAUDITED CONSOLIDATED STATEMENT OF CASH FLOWS

 For the Three Months Ended

 Cash Flows from Operating Activities:

 $

 $

 $

 Adjustments to reconcile net income (loss) to net cash used in operating activities:

 ( 343,529
)

 ( 22,202
)

 ( 365,731
)

 Changes in operating assets and liabilities:

 Decrease in prepayment

 ( 54,828
)

 —

 ( 54,828
)

 Decrease in accrual and other payable

 ( 3,636
)

 —

 ( 3,636
)

 —

 ( 137,702
)

 ( 107,702
)

 Cash Flows from Investing Activities:

 Proceeds deposited in Trust Account

)

 —

)

 Net cash used in investing activities

)

 —

)

 Cash Flows from Financing Activities:

 Advance from a related party

 ( 30,000

)

 —

 Net cash provided by financing activities

 ( 30,000
)

 —

 Net Change in Cash

 ( 134,942
)

 —

 ( 134,942
)

 Cash, Beginning of the period

 —

 Cash, End of the period

 $

 $
 —

 $

 Supplemental Disclosure of Non-cash Financing Activities

 $
 370,769

 $

 $
 392,971

 F- 18

 HHG

UNAUDITED CONSOLIDATED BALANCE SHEET

 June
30, 2023

 Cash

 $

 $
 —

 $

 39,305

 —

 39,305

 Total Current Assets

 78,689

 —

 78,689

 35,143,815

 Total Assets

 $
 35,222,504

 $

 $

 $
 57,536

 $
 —

 $
 57,536

 —

 Total Current Liabilities

 267,536

 —

 267,536

 Deferred underwriting fee payable

 —

 Total Liabilities

 1,882,536

 —

 1,882,536

 Commitments and Contingencies

 -

 -

 -

 Ordinary shares subject to possible redemption, 3,356,406 shares issued and outstanding at redemption value

 35,143,815

 Ordinary shares, $ 0.0001 par value; 500,000,000 shares authorized; 1,727,000 shares issued and outstanding (excluding 3,356,406 shares subject to redemption)

 —

 ( 1,804,019
)

 —

 ( 1,804,019
)

 Total Stockholders' Deficit

 ( 1,803,847
)

 —

 ( 1,803,847
)

 Total Liabilities, Temporary Equity, and Stockholders' Deficit

 $
 35,222,504

 $

 $

 F- 19

 HHG

 Three Months Ended
 June 30, 2023

 $
 ( 204,379
)

 $
 —

 $
 ( 204,379
)

 401,703

 415,654

 —

 402,367

 416,318

 $
 197,988

 $

 $
 211,939

 Basic and diluted weighted average shares outstanding, common stock subject to possible redemption

 —

 Basic and diluted net income per share, common stock subject to possible redemption

 $
 0.08

 $
 0.01

 $
 0.09

 Basic and diluted weighted average shares outstanding, non-redeemable common stock

 —

 $
 ( 0.05
)

 $
 —

 $
 ( 0.05
)

 F- 20

 HHG

 Six Months Ended
 June 30, 2023

 $
 ( 286,424
)

 $
 —

 $
 ( 286,424
)

 745,232

 781,385

 3,471

 —

 3,471

 748,703

 784,856

 $
 462,279

 $

 $

 Basic and diluted weighted average shares outstanding, common stock subject to possible redemption

 —

 Basic and diluted net income per share, common stock subject to possible redemption

 $
 0.17

 $
 0.01

 $
 0.18

 Basic and diluted weighted average shares outstanding, non-redeemable common stock

 —

 $
 ( 0.07
)

 $
 —

 $
 ( 0.07
)

 F- 21

 HHG

UNAUDITED CONSOLIDATED STATEMENT OF CASH FLOWS

 For the Six Months Ended
 June 30, 2023

 Cash Flows from Operating Activities:

 $
 462,279

 $

 $

 Adjustments to reconcile net income (loss) to net cash used in operating activities:

 ( 745,232
)

 ( 36,153
)

 ( 781,385
)

 Changes in operating assets and liabilities:

 Increase in prepayment

 ( 33,280
)

 —

 ( 33,280
)

 Increase in accrual and other payable

 21,229

 —

 21,229

 —

 ( 295,004
)

 ( 235,004
)

 Cash Flows from Investing Activities:

 Proceeds deposited in Trust Account

)

 —

)

 Net cash used in investing activities

)

 —

)

 Cash Flows from Financing Activities:

 Advance from a related party

 ( 60,000
)

 —

 Net cash provided by financing activities

 ( 60,000

)

 —

 Net Change in Cash

 ( 289,485
)

 —

 ( 289,485
)

 Cash, Beginning of the period

 —

 Cash, End of the period

 $

 $
 —

 $

 Supplemental Disclosure of Non-cash Financing Activities

 Accretion of carrying value to redemption value

 $
 799,713

 $

 $
 835,866

 F- 22

 HHG

UNAUDITED CONSOLIDATED BALANCE SHEET

 September
30, 2023

 Cash

 $
 6,546

 $
 —

 $
 6,546

 19,256

 —

 19,256

 Total Current Assets

 25,802

 —

 25,802

 35,262,118

 Total Assets

 $
 35,287,920

 $

 $

 $
 162,225

 $
 —

 $
 162,225

 Promissory note - related party

 —

 Total Current Liabilities

 202,225

 —

 202,225

 Deferred underwriting fee payable

 —

 Total Liabilities

 1,817,225

 —

 1,817,225

 Commitments and Contingencies

 -

 -

 -

 Ordinary shares subject to possible redemption, 3,356,406 shares issued and outstanding at redemption value

 35,262,118

 Ordinary shares, $ 0.0001 par value; 500,000,000 shares authorized; 1,727,000 shares issued and outstanding (excluding 3,356,406 shares subject to redemption)

 —

 ( 1,791,595
)

 —

 ( 1,791,595
)

 Total Stockholders' Deficit

 ( 1,791,423
)

 —

 ( 1,791,423
)

 Total Liabilities, Temporary Equity, and Stockholders' Deficit

 $
 35,287,920

 $

 $

 F- 23

 HHG

 Three Months Ended

 $
 ( 171,430
)

 $
 —

 $
 ( 171,430
)

 453,381

 6,216

 459,597

 Other income

 663,381

 6,216

 669,597

 $
 491,951

 $
 6,216

 $
 498,167

 Basic and diluted weighted average shares outstanding, common stock subject to possible redemption

 —

 Basic and diluted net income per share, common stock subject to possible redemption

 $
 0.15

 $
 —

 $
 0.15

 Basic and diluted weighted average shares outstanding, non-redeemable common stock

 —

 $
 0.00

 $
 —

 $
 0.00

 F- 24

 HHG

 Nine Months Ended

 $
 ( 457,854
)

 $
 —

 $
 ( 457,854
)

 1,198,613

 1,240,982

 3,471

 —

 3,471

 Other income

 —

 1,412,084

 1,454,453

 $
 954,230

 $

 $

 Basic and diluted weighted average shares outstanding, common stock subject to possible redemption

 3,353,444

 —

 Basic and diluted net income per share, common stock subject to possible redemption

 $
 0.32

 $
 0.01

 $
 0.33

 Basic and diluted weighted average shares outstanding, non-redeemable common stock

 —

 $
 ( 0.06
)

 $
 —

 $
 ( 0.06
)

 F- 25

 HHG

UNAUDITED CONSOLIDATED STATEMENT OF CASH FLOWS

 For the Nine Months Ended

 Cash Flows from Operating Activities:

 $
 954,230

 $

 $

 Adjustments to reconcile net income (loss) to net cash used in operating activities:

 ( 1,198,613
)

)

 ( 1,240,982
)

 Waiver of amount due to a related party

 ( 210,000
)

 —

 ( 210,000
)

 Changes in operating assets and liabilities:

 Increase in prepayment

 ( 13,231
)

 —

 ( 13,231
)

 Increase in accrual and other payable

 125,918

 —

 125,918

 —

 ( 281,696
)

 —

 ( 281,696
)

 Cash Flows from Investing Activities:

 Proceeds deposited in Trust Account

 ( 80,627
)

 —

 ( 80,627
)

 Withdraw of investments in Trust Account

 361,224

 —

 361,224

 Net cash used in investing activities

 280,597

 —

 280,597

 Cash Flows from Financing Activities:

 Proceeds from issuance of promissory note

 —

 Redemption of ordinary shares

)

 —

)

 Net cash provided by financing activities

 ( 321,224
)

 —

 ( 321,224
)

 Net Change in Cash

 ( 322,323
)

 —

 ( 322,323
)

 Cash, Beginning of the period

 —

 Cash, End of the period

 $
 6,546

 $
 —

 $
 6,546

 Supplemental Disclosure of Non-cash Financing Activities

 $
 ( 1,279,240
)

 $
)

 $
 ( 1,321,609
)

 F- 26

 NOTE
3 – SIGNIFICANT ACCOUNTING POLICIES

 Basis of presentation

 These
accompanying consolidated financial statements have been prepared in accordance with U.S. GAAP and pursuant to the rules and regulations
of the SEC.

 Principles
 of consolidation

 The
consolidated financial statements include the financial statements of the Company and its subsidiaries. All significant intercompany
transactions and balances between the Company and its subsidiaries are eliminated upon consolidation.

 Subsidiaries
are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to
govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a
majority of votes at the meeting of directors.

 The
accompanying consolidated financial statements reflect the activities of the Company and each of the following entities:

 SUMMARY OF SUBSIDIARY COMPANY OWNERSHIP

 Name

 Background

 Ownership

 Perfect
 Hexagon Holdings Limited ("Purchaser")

 A
 British Virgin Islands company Incorporated on April 20, 2023

 100 %
 Owned by the Company

 Perfect
 Acquisitions Limited ("Merger Sub")

 A
 British Virgin Islands company Incorporated on April 27, 2023

 100 %
 Owned by Purchaser

 Emerging growth company

 The
Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the "JOBS Act"), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced
disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously
approved.

 Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company's consolidated financial statements
with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the
extended transition period difficult or impossible because of the potential differences in accounting standards used.

 F- 27

 Use
 of estimates

 In
preparing these consolidated financial statements in conformity with U.S. GAAP, management makes estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported expenses during the reporting period.

 Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, actual results may differ from
these estimates.

 Cash and cash equivalents

 The
Company's cash consists of deposit with financial institution. The Company considers all short-term investments with an original
maturity of three months or less when purchased to be cash equivalents. The Company did no t have any cash equivalents as of December
31, 2023 and 2022.

 Concentration of credit risk

 Financial
instruments that potentially subject the Company to the concentration of credit risk consist of these cash accounts in a financial institution.
The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such
account.

 At
December 31, 2023 and 2022, substantially all of the assets held in the Trust Account were held in money market funds. Assets held in
money market funds were invested primarily in U.S. Treasury securities. The Company classifies marketable securities as available-for-sale
at the time of purchase and reevaluates such classification as of each balance sheet date. All marketable securities are recorded at
their fair value. Unrealized gains and losses for available-for-sale securities are recorded in other comprehensive income. The Company
evaluates its investments to assess whether those with unrealized loss positions are other than temporarily impaired. Impairments are
considered other than temporary if they are related to deterioration in credit risk or if it is likely the Company will sell the securities
before the recovery of the cost basis. Realized gains and losses and declines in value determined to be other than temporary are determined
based on the specific identification method and are reported in other income, net in the consolidated statements of comprehensive income. The interest income was recognized when the interest income earned during
the year.

 Warrant
 accounting

 The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant's
specific terms and applicable authoritative guidance in Financial Accounting Standards Board ("FASB") Accounting Standards
Codification ("ASC") Topic 480, " Distinguishing Liabilities from Equity " ("ASC 480") and ASC
Topic 815, " Derivatives and Hedging" ("ASC 815"). The assessment considers whether the warrants are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all
of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company's own ordinary
shares and whether the warrant holders could potentially require "net cash settlement" in a circumstance outside of the Company's
control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted
at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

 F- 28

 For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component
of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants
are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of comprehensive income
(loss).

 As
the warrants issued upon the IPO and private placements meet the criteria for equity classification under ASC 480, therefore, the warrants
are classified as equity.

 The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary shares subject
to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary
shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption
upon the occurrence of uncertain events not solely within the Company's control) are classified as temporary equity. At all other
times, ordinary shares are classified as shareholders' equity. The Company's ordinary shares issued upon the consummation
of the IPO and the exercise of the over-allotment option feature certain redemption rights that are considered to be outside of the Company's
control and subject to occurrence of uncertain future events. Accordingly, at December 31, 2023 and 2022, ordinary shares subject to
possible redemption are presented as temporary equity, outside of the shareholders' equity section of the Company's consolidated
balance sheets.

 The
Company has made a policy election in accordance with ASC 480-10-S99-3A and recognizes changes in redemption value in additional paid-in
capital or accumulated deficit if additional paid in capital equals to zero over an expected 12-month period leading up to a Business
Combination. For the years ended December 31, 2023 and 2022, the Company recorded $ 1,816,832 and $ 9,535,725 accretion of carrying value
to redemption value, respectively.

 Income
 taxes

 Income
taxes are determined in accordance with the provisions of ASC Topic 740, "Income Taxes" ("ASC 740"). Under this
method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are
measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected
to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the
period that includes the enactment date.

 ASC
740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their consolidated financial
statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized
in the consolidated financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities.
The Company's management determined that the British Virgin Islands is the Company's major tax jurisdiction. The Company
recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized
tax benefits and no amounts accrued for interest and penalties as of December 31, 2023 and 2022. The Company is currently not aware of
any issues under review that could result in significant payments, accruals or material deviation from its position.

 The
Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations
may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with
foreign tax laws. The Company's management does not expect that the total amount of unrecognized tax benefits will materially change
over the next twelve months.

 The
Company's tax provision is zero for the years ended December 31, 2023 and 2022.

 The
Company is considered to be an exempted British Virgin Islands Company and is presently not subject to income taxes or income tax filing
requirements in the British Virgin Islands or the United States.

 F- 29

 Net
 income per share

 The
Company complies with accounting and disclosure requirements of ASC Topic 260, "Earnings Per Share" ("ASC 260").
In order to determine the net income attributable to both the redeemable shares and non-redeemable shares, the Company first considered
the undistributed income allocable to both the redeemable common stock and non-redeemable common stock and the undistributed income
is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income ratably
based on the weighted average number of shares outstanding between the redeemable and non-redeemable ordinary share. Any remeasurement
of the accretion to redemption value of the ordinary share subject to possible redemption was considered to be dividends paid to the
public shareholders. As of December 31, 2023 and 2022, the Company has not considered the effect of the warrants sold in the Initial
Public Offering in the calculation of diluted net income per share, since the exercise of the warrants is contingent upon the
occurrence of future events and the inclusion of such warrants would be anti-dilutive and the Company did not have any other dilutive
securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of
the Company. As a result, diluted income per share is the same as basic income per share for the period presented.

 The
net income (loss) per share presented in the statement of comprehensive loss is based on the following:

 SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED

 For the Years Ended

 (As
 Restated)

 $

 $

 Accretion of carrying value to redemption value

 ( 1,816,832
)

 ( 9,535,725
)

 Net loss including accretion of carrying value to redemption value

 $
 ( 444,251
)

 $
 ( 9,472,518
)

 SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED BY ORDINARY SHARE

 For the Years Ended

 Redeemable

 Non-Redeemable

 Redeemable

 Non-Redeemable

 Ordinary Share

 Ordinary Share

 Ordinary Share

 Ordinary Share

 Basic and diluted net loss per share:

 -

 -

 -

 -

 Numerators:

 Allocation of net loss including carrying value to redemption value

 $
 ( 293,057
)

 $
 ( 151,194
)

 $
 ( 7,071,953
)

 $
 ( 2,400,565
)

 Accretion of carrying value to redemption value

 1,816,832

 -

 9,535,725

 -

 Allocation of net income (loss)

 $
 1,523,775

 $
 ( 151,194
)

 $
 2,463,772

 $
 ( 2,400,565
)

 Denominators:

 Weighted-average shares outstanding

 3,347,407

 5,087,663

 Basic and diluted net income (loss) per share

 $
 0.46

 $
 ( 0.09
)

 $
 0.48

 $
 ( 1.39
)

 F- 30

 Related parties

 Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control
the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also
considered to be related if they are subject to common control or common significant influence.

 Fair
 value of financial instrument

 ASC
Topic 820 " Fair Value Measurements " ("ASC 820") defines fair value, the methods used to measure fair value
and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to
transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the
valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC
820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset
or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller
would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs
reflect the Company's assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed
based on the best information available in the circumstances.

 The
fair value hierarchy is categorized into three levels based on the inputs as follows:

 Level
 1 —

 Valuations
based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation
adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available
in an active market, valuation of these securities does not entail a significant degree of judgment.

 Level
 2 —

 Valuations
based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for
identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally
from or corroborated by market through correlation or other means.

 Level
 3 —

 Valuations
 based on inputs that are unobservable and significant to the overall fair value measurement.

 The
fair value of the Company's certain assets and liabilities, which qualify as financial instruments under ASC 820 approximates the
carrying amounts represented in the consolidated balance sheets. The fair values of cash, and other current assets,
accrued expenses, amount due to sponsor are estimated to approximate the carrying values as of December 31, 2023 and 2022 due to the
short maturities of such instruments. The Company measured its investments held in trust account at fair value on a recurring basis as
of December 31, 2023 and 2022 and the fair value is based on Level 1 inputs.

 The
following table presents information about the Company's assets and liabilities that were measured at fair value on a recurring
basis as of December 31, 2023 and 2022, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine
such fair value.

 SCHEDULE OF FAIR VALUE HIERARCHY OF THE VALUATION TECHNIQUES

 December 31,

 Quoted
Prices In Active Markets

 Significant Other
 Observable Inputs

 Significant Other
 Unobservable Inputs

 Description

 2023

 (Level 1)

 (Level 2)

 (Level 3)

 Assets:

 Money market funds invested in U.S. Treasury*

 $

 $

 $
 -

 $
 -

 F- 31

 December 31,

 Quoted Prices In
 Active Markets

 Significant Other
 Observable Inputs

 Significant Other
 Unobservable Inputs

 Description

 2022

 (Level 1)

 (Level 2)

 (Level 3)

 Assets:

 Money market funds invested in U.S. Treasury *

 $

 $

 $
 -

 $
 -

 *

 included
 in investments held in trust account on the Company's consolidated balance sheets.

 Recent
 accounting pronouncements

 In
December 2023, the FASB issued Accounting Standards Update 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosure"
("ASU 2023-09"). ASU 2023-09 mostly requires, on an annual basis, disclosure of specific categories in an entity's
effective tax rate reconciliation and income taxes paid disaggregated by jurisdiction. The incremental disclosures may be presented on
a prospective or retrospective basis. The ASU is effective for fiscal years beginning after December 15, 2024 with early adoption permitted.
The Company is currently assessing the impact, if any, that ASU 2023-09 would have on its financial position, results of operations or
cash flows.

 The
Company has considered all new accounting pronouncements and has concluded that there are no other new pronouncements that may have a
material impact on the results of operations, financial condition, or cash flows, based on the current information.

 NOTE
4 – INVESTMENTS HELD IN TRUST ACCOUNT

 As
of December 31, 2023, investment securities in the Company's Trust Account consisted of $ 35,909,651 in Money Marketing Fund ("MMF")
that invests in U.S. treasury securities. As of December 31, 2022, investment securities in the Company's Trust Account consisted
of $ 34,454,043 in MMF that invests in U.S. treasury securities. The Company classifies its MMF as available-for-sale. Available-for-sale
marketable securities are recorded at their fair value on the accompanying December 31, 2023 and 2022 consolidated balance sheets. No
unrealized holding gain and fair value of available-for-sale marketable securities on December 31, 2023 and 2022.

 SCHEDULE OF INVESTMENT HELD IN TRUST ACCOUNT

 For the Year Ended

 For the Year Ended

 Balance brought forward

 $

 $
 58,076,283

 Gross proceeds from IPO

 -

 -

 Plus:

 Dividend income earned in Trust Account

 1,712,250

 616,543

 Business combination extension fee

 104,582

 36,321

 Gross unrealized holding gain

 -

 Reclassification of realized gain on available-for-sale securities, net to net income

 -

)

 Less:

 Share redemption during the year

)

 ( 24,274,780
)

 Balance carried forward

 $

 $

 F- 32

 NOTE
5 – INITIAL PUBLIC OFFERING

 On
September 23, 2021, the Company sold 5,000,000 Public Units at a price of $ 10.00 per Unit. Simultaneously, the Company sold an additional
 750,000 units to cover over-allotments. Each Public Unit consists of one ordinary share, one right ("Public Right") and one
redeemable warrant ("Public Warrant"). Each Public Right will convert into one-tenth (1/10) of one ordinary share upon the
completion of the initial Business Combination. Each Public Warrant will entitle the holder to purchase three-fourth (3/4) of one ordinary
share at an exercise price of $ 11.50 per whole share. The Company will not issue fractional shares upon the exercise of the Public Warrant
or the conversion of the Public Right.

 The
Company paid an upfront underwriting discount of $ 805,000, equal to 1.4 % of the gross offering proceeds to the underwriter at the closing
of the Initial Public Offering, with an additional fee of $ 1,615,000 (the "Deferred Underwriting Discount"). The Deferred
Underwriting Discount will become payable to the underwriter from the amounts held in the Trust Account solely in the event the Company
completes its Business Combination. In the event that the Company does not close the Business Combination, the underwriter has waived
its right to receive the Deferred Underwriting Discount. The underwriter is not entitled to any interest accrued on the Deferred Underwriting
Discount.

 Besides
the upfront underwriting discount of $ 805,000 and the Deferred Underwriting Discount of $ 1,615,000, the Company also incurred other offering
expenses of $ 297,023. The Company allocates offering costs totaled $ 2,717,023 between Public Shares, Public Warrants and Public Rights
based on the estimated fair value of each at the date of issuance. Accordingly, $ 2,284,236 offering cost was allocated to Public Shares,
$ 432,787 offering cost was allocated to Public Warrants and Public Rights.

 As
a result of the aforementioned allocation, upon the completion of the IPO, $ 46,245,764 is allocated to the ordinary shares included in
the Public Units and recorded as temporary equity and $ 8,537,213 is allocated to the Public Warrants and Public Rights and is recorded
as part of the additional paid-in capital.

 NOTE
6 – PRIVATE PLACEMENT

 Simultaneously
with the closing of the Initial Public Offering, the Company consummated the private placement ("Private Placement") with
its sponsor of 255,000 units (the "Private Units") at a price of $ 10.00 per Private Unit, generating total proceeds of $ 2,550,000.
 Each Private Unit consists of one Private Share, one Private Right ("Private Right") and one redeemable warrant (each, a
"Private Warrant"). Each Private Right will convert into one-tenth (1/10) of one ordinary share upon the completion of the
Business Combination. Each Private Warrant is exercisable to purchase three-fourth (3/4) of one ordinary share at a price of $ 11.50 per
share. The Company will not issue fractional shares upon the exercise of the Public Warrant or the conversion of the Public Right.

 The
Private Units are identical to the units sold in the Initial Public Offering except with certain registration rights and transfer restrictions.

 NOTE
7 – RELATED PARTY TRANSACTIONS

 Insider
Shares

 In
July 2020, the Company issued an aggregate of 10,000 founder shares to the initial shareholders for an aggregate purchase price of $ 1.

 In
November 2020, the Company issued an aggregate of 1,240,000 additional founder shares to the initial shareholders for an aggregate purchase
price of $ 24,999.

 In
February 2021, the Company issued an aggregate of 187,500 additional founder shares to the initial shareholders for an aggregate purchase
price of $ 18. These shares are subject to forfeiture to the extent that the underwriters' over-allotment option is not exercised
in full or in part. As the over-allotment option was exercised in full in the IPO, none of these shares were forfeited.

 F- 33

 Promissory
Note – Related Party

 On
each of August 8, 2023, October 9, 2023 and November 17, 2023, the Company issued an unsecured promissory note to the Sponsor,
pursuant to which the Company may borrow up to an aggregate principal amount of $ 80,000,
$ 100,000
and $ 20,000
(the "Promissory Note"), respectively. The Promissory Note is non-interest bearing and payable upon consummation of
business combination.

 As
of December 31, 2023 and 2022, the Sponsor had advanced the Company an aggregate amount of $ 200,000 and $ 0, respectively.

 Working
Capital Loan

 In
order to finance transaction costs in connection with a Business Combination, the Company's Sponsor or an affiliate of the Sponsor,
or the Company's officers and directors may, but are not obligated to, loan the Company funds as may be required ("Working
Capital Loans"). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation
of a Business Combination, without interest, or, at the lender's discretion, up to $ 500,000 of notes may be converted upon consummation
of a Business Combination into additional Private Units at a price of $ 10.00 per Unit. In the event that a Business Combination does
not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds
held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2023 and 2022, there was no outstanding
balance under the Working Capital Loans.

 Administrative
Services Agreement

 The
Company is obligated, commencing from the date of the consummation of the offering, to pay the Sponsor a monthly fee of $ 10,000 for general
and administrative services. This agreement will terminate upon completion of the Company's Business Combination or the liquidation
of the trust account to public shareholders. For the years ended December 31, 2023 and 2022, the Company incurred $ 60,000 and $ 120,000
expenses, respectively, in connection with the execution of the administrative service agreement. On September 4, 2023, the Sponsor agreed
to waive monthly fee of $ 10,000 commencing from July 1, 2023 and all the $ 210,000 outstanding balance due to the Sponsor as of June 30,
2023. The Company recognized waiver of amount of $ 210,000 as other income in the consolidated statements of comprehensive income. As of December 31, 2023 and 2022, the Company had unpaid administrative service monthly fee of $ 0 and $ 150,000, respectively,
which are recorded as amounts due to a related party in the respective consolidated balance sheets.

 Private
Placement

 The
Company consummated the Private Placement with its Sponsor of 255,000 Private Units at a price of $ 10.00 per Private Unit, generating
total proceeds of $ 2,550,000. Refer to Note 6 for details.

 Waiver
Agreement

 On
August 17, 2022, the Company entered into the Waiver Agreement with the Sponsor and the Anchor Shareholders, who agreed to waive their
pro rata share of all Extension Payments made into the Trust Account after the date thereof. As a result, each Extension Payment that
would be paid into the Trust Account after August 18, 2022 is to be segregated so that only the Company's public shareholders
who have not redeemed their ordinary shares, excluding the Anchor Shareholders, would receive their pro rata share of each such monthly
extension payment (in addition to their pro rata share of amounts then in the Trust Account) upon redemption or upon the liquidation
of the Company. The Waiver Agreement also provides that the Anchor Shareholders agreed not to sell or otherwise transfer
any of their Waiver Shares (subject to customary exceptions for transfers to certain family members and other affiliates) other than
in connection with a redemption of their Waiver Shares or in the event that the Company is forced to dissolve or liquidate.

 F- 34

 NOTE
8 – SHAREHOLDER'S EQUITY

 On
September 23, 2021, the Company completed the Initial Public Offering and issued an aggregate of 5,750,000 Public Units and raised gross
proceeds of $ 57,500,000. Refer to Note 5 for details. Simultaneously, the Company completed a private placement and issued an aggregate
of 255,000 Private Units and raised gross proceeds of $ 2,550,000. Refer to Note 6 for details.

shares

 The
Company is authorized to issue 500,000,000 ordinary shares at par $ 0.0001. Holders of the Company's ordinary shares are entitled
to one vote for each share.

 Rights

 Each
holder of a right (including Public Rights and Private Rights) will automatically receive one-tenth (1/10) of one ordinary share upon
consummation of a Business Combination, even if the holder of such right redeemed all shares held by it in connection with a Business
Combination. No fractional shares will be issued upon exchange of the rights. In the event the Company will not be the surviving company
upon completion of a Business Combination, each holder of a right will be required to affirmatively convert the rights in order to receive
the one-tenth (1/10) of an ordinary share underlying each right upon consummation of a Business Combination.

 If
the Company is unable to complete a Business Combination within the required time period and the Company redeems the Public Shares for
the funds held in the trust account, holders of rights will not receive any of such funds for their rights and the rights will expire
worthless.

 Warrants

 The
Public Warrants will become exercisable on the later of (a) the completion of a Business Combination or (b) 12 months from the closing
of the Initial Public Offering. No Public Warrants will be exercisable for cash unless the Company has an effective and current registration
statement covering the ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to such ordinary
shares. Notwithstanding the foregoing, if a registration statement covering the ordinary shares issuable upon the exercise of the Public
Warrants is not effective within 90 days from the consummation of a Business Combination, the holders may, until such time as there is
an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement,
exercise the Public Warrants on a cashless basis pursuant to the exemption from registration provided by Section 3(a)(9) of the Securities
Act provided that such exemption is available. If an exemption from registration is not available, holders will not be able to exercise
their Public Warrants on a cashless basis. The Public Warrants will expire five years after the completion of the Business Combination,
at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

 The
Company may call the warrants for redemption, in whole and not in part, at a price of $ 0.01 per warrant:

 at
 any time while the Public Warrants are exercisable,

 upon
 not less than 30 days' prior written notice of redemption to each Public Warrant holder,

 if,
 and only if, the reported last sale price of the ordinary shares equals or exceeds $ 16.5 per share, for any 20 trading days within
 a 30 trading day period ending on the third trading day prior to the notice of redemption to Public Warrant holders, and

 if,
 and only if, there is a current registration statement in effect with respect to the issuance of the ordinary shares underlying such
 warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter
 until the date of redemption.

 The
Private Warrants are identical to the Public Warrants underlying the Units being sold in the Initial Public Offering. The Private Warrants
(including the ordinary shares issuable upon exercise of the private warrants) will not be transferable, assignable or salable until
30 days after the completion of the initial Business Combination.

 If
the Company calls the warrants for redemption, management will have the option to require all holders that wish to exercise the warrants
to do so on a "cashless basis," as described in the warrant agreement. The exercise price and number of ordinary shares issuable
upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend
or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances of ordinary shares
at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company
is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account,
holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the
Company's assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.

 The
Company assessed the key terms applicable to the Public Warrants as well as the Private Warrants and classified the Public Warrants and
Private Warrants as equity in accordance with ASC 480 and ASC 815.

 F- 35

 NOTE
9 – ORDINARY SHARE SUBJECT TO POSSIBLE REDEMPTION

 The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary shares subject
to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary
shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption
upon the occurrence of uncertain events not solely within the Company's control) are classified as temporary equity. At all other
times, ordinary shares are classified as shareholders' equity. The Company's Public Shares feature certain redemption rights
that are subject to the occurrence of uncertain future events and considered to be outside of the Company's control. On September
21, 2022, upon the Company's shareholders approval of the Charter Amendment, 2,393,594 shares were redeemed by certain shareholders
at a price of approximately $ 10.12 per share, including dividend generated in the Trust Account, in an aggregate amount of $ 24,223,171.
On December 1, 2022, the aggregate amount adjusted to $ 24,274,780. On September 21, 2023, upon the Company's shareholders approval
of the Charter Amendment II, 32,845 shares were redeemed by certain shareholders at a price of approximately $ 11.00 per share, including
dividend generated in the Trust Account, in an aggregate amount of $ 361,224.

 Accordingly,
at December 31, 2023 and 2022, 3,323,561 and 3,356,406 ordinary shares subject to possible redemption, respectively, are presented as
temporary equity, outside of the shareholders' deficit section of the Company's consolidated balance sheets.

 SCHEDULE
OF EXTENSION PAYMENTS DEPOSITED IN TRUST ACCOUNT

 Total ordinary shares issued

 7,477,000

 7,477,000

 Share issued classified as equity

 ( 1,727,000
)

 ( 1,727,000
)

 Share redemption

 ( 2,426,439
)

 ( 2,393,594
)

 Ordinary shares, subject to possible redemption

 3,323,561

 NOTE
10 – COMMITMENTS AND CONTINGENCIES

 Risks
and Uncertainties

 United
States and global markets are experiencing volatility and disruption following the geopolitical instability resulting from the invasion
of Ukraine by Russia and conflicts in the Middle East and around the Red Sea. In response to the ongoing Russia-Ukraine conflict, the
North Atlantic Treaty Organization ("NATO") deployed additional military forces to eastern Europe, and the United States,
the United Kingdom, the European Union and other countries have announced various sanctions and restrictive actions against Russia, Belarus
and related individuals and entities, including the removal of certain financial institutions from the Society for Worldwide Interbank
Financial Telecommunication (SWIFT) payment system. Certain countries, including the United States, have also provided and may continue
to provide military aid or other assistance, increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia
and conflicts in the Middle East and around the Red Sea and the resulting measures that have been taken, and could be taken in the future,
by NATO, the United States, the United Kingdom, the European Union, Middle East and other countries have created global security concerns
that could have a lasting impact on regional and global economies. Although the length and impact of the ongoing conflicts are highly
unpredictable, they could lead to market disruptions, including significant volatility in commodity prices, credit and capital markets,
as well as supply chain interruptions and increased cyber-attacks against U.S. companies. Additionally, any resulting sanctions could
adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets.

 Any
of the above mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions
resulting from the Russian invasion of Ukraine, conflicts in the Middle East and around the Red Sea and subsequent sanctions or related
actions, could adversely affect the Company's search for an initial business combination and any target business with which the
Company may ultimately consummate an initial business combination.

 Registration
Rights

 The
holders of the insider shares, the Private Units (and their underlying securities) and the warrants that may be issued upon conversion
of the Working Capital Loans (and their underlying securities) are entitled to registration rights pursuant to a registration rights
agreement signed on September 20, 2021. The holders of a majority of these securities will be entitled to make up to two demands that
the Company register such securities. The holders of the majority of the insider shares can elect to exercise these registration rights
at any time commencing three months prior to the date on which these ordinary shares are to be released from escrow. The holders of a
majority of the Private Units and warrants issued in payment of Working Capital Loans made to the Company (or underlying securities)
can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders
will have certain "piggy-back" registration rights with respect to registration statements filed subsequent to the completion
of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 Underwriting
Agreement

 The
underwriters were entitled to an underwriting fee of 3.2 % of the gross proceeds from offering to the maximum of $ 1,615,000. A total of
$ 805,000 was paid upon the closing of the Initial Public Offering. At the closing of any Business Combination, the Underwriters will
receive a cash payment equal to the greater of: (i)$ 575,000 or (ii) a fee equal to 4.5 % (or 0.5 % with respect to investors in the Offering
introduced to the Underwriters by the Company's sponsor, or Company's management, subject to a total maximum underwriting
fee of $ 1,615,000.

 F- 36

 NOTE
11 – RESTATEMENT OF PREVIOUSLY ISSUED UNAUDITED FINANCIAL
STATEMENTS

 As
further described in Note 2, the previously reported financial information for the quarters ended March 31, 2023, June 30, 2023, and
September 30, 2023, have been restated. As part of the restatement, the Company recorded adjustments to correct the accrual basis interest
earned on investments held in Trust Account in the impacted periods. The audited and unaudited interim financial statements reflect all
adjustments which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented.

 The
following tables summarize the Company's unaudited quarterly financial information for the impacted periods.

 Incorporated
herein is expanded disclosure of the restatements of the quarterly information for the three months ended March 31, 2023, three and six-months
ended June 30, 2023, and three and nine-months ended September 30, 2023.

 F- 37

 SCHEDULE OF RESTATED FINANCIAL STATEMENTS

HHG CAPITAL CORPORATION

CONSOLIDATED BALANCE SHEETS

 3/31/2023

 6/30/20232

 9/30/2023

 As

 3/31/2023

 6/30/2023

 9/30/2023

 Cash

 $

 $

 $
 6,546

 60,853

 39,305

 19,256

 Total
 Current Assets

 254,780

 78,689

 25,802

 Total

 $

 $

 Liabilities,
 Temporary Equity, and Stockholders' Deficit

 Accrual
 and other payable

 $
 32,671

 57,536

 162,225

 due to a related party

 180,000

 Total
 Current Liabilities

 212,671

 267,536

 202,225

 Deferred
 underwriting fee payable

 Total
 Liabilities

 1,827,671

 1,882,536

 1,817,225

 Commitments
 and Contingencies

 -

 -

 -

 shares subject to possible redemption, 3,356,406, 3,356,406
 and 3,323,561
 shares issued and outstanding at redemption value, respectively

 Stockholders'
 Deficit

 shares, $ 0.0001
 par value; 500,000,000
 shares authorized; 1,727,000
 shares issued and outstanding (excluding 3,356,406,
 3,356,406 and 3,323,561 shares subject to redemption, respectively)

 Accumulated
 deficit

 ( 1,573,063
)

 ( 1,804,019
)

 ( 1,791,595
)

 Total

 ( 1,572,891
)

 ( 1,803,847
)

 ( 1,791,423
)

 Total

 $

 $

 $

 F- 38

 HHG

CONSOLIDATED STATEMENTS OF INCOME

 2023

 2023

 September 30,
 2023

 September 30,
 2023

 AS

 For
 the three months ended

 For
 the three months ended
 2023

 For
 the six months ended
 2023

 For
 the three months ended
 September 30,
 2023

 For
 the nine months ended
 September 30,
 2023

 General
 and administrative expenses

 $
 ( 82,045
)

 $
 ( 204,379
)

 $
 ( 286,424
)

 $
 ( 171,430
)

 $
 ( 457,854
)

 Other
 income:

 365,731

 415,654

 781,385

 459,597

 1,240,982

 Interest

 2,807

 3,471

 —

 3,471

 Other income

 —

 —

 —

 Total other

 368,538

 416,318

 784,856

 669,597

 1,454,453

 $

 $
 211,939

 $

 $
 498,167

 $

 diluted weighted average shares outstanding, common stock subject to possible redemption

 diluted net income per share, common stock subject to possible redemption

 $
 0.10

 $
 0.09

 $
 0.18

 $
 0.15

 0.33

 diluted weighted average shares outstanding, non-redeemable common stock

 diluted net loss per share, non-redeemable common stock

 $
 ( 0.02
)

 $
 ( 0.05
)

 $
 ( 0.07
)

 $
 0.00

 ( 0.06
)

 F- 39

 HHG

CONSOLIDATED STATEMENTS OF CASH FLOWS

 June 30, 2023

 As

 For
 the three months ended

 For
 the six months ended
 2023

 For
 the nine months ended

 Cash
 Flows from Operating Activities:

 Net

 $

 $

 $

 to reconcile net income (loss) to net cash used in operating activities:

 ( 365,731
)

 ( 781,385
)

 ( 1,240,982
)

 Waiver
 of amount due to a related party

 —

 —

 ( 210,000
)

 Changes
 in operating assets and liabilities:

 Increase
 in prepayment

 ( 54,828
)

 ( 33,280
)

 ( 13,231
)

 Increase
 in accrual and other payable

 ( 3,636
)

 21,229

 125,918

 due to a related party

 Net
 cash used in operating activities

 ( 107,702
)

 ( 235,004
)

 ( 281,696
)

 Cash
 Flows from Investing Activities:

 Withdraw
 of investment in Trust Account

 —

 —

 361,224

 Proceeds
 deposited in Trust Account

)

)

 ( 80,627
)

 Net
 cash provided by (used in) investing activities

)

)

 280,597

 Cash
 Flows from Financing Activities:

 Common stock
 redemption

 —

 —

)

 Proceeds
 from issuance of promissory note

 —

 —

 Net
 cash used in financing activities

 —

 —

 ( 321,224
)

 Net
 Change in Cash

 ( 134,942
)

 ( 289,485
)

 ( 322,323
)

 Cash,
 Beginning of the period

 Cash,
 End of the period

 $

 $

 $
 6,546

 Supplemental
 Disclosure of Non-cash Financing Activities

 Accretion
 of carrying value to redemption value

 $
 392,971

 $
 835,866

 $
 ( 1,321,609
)

 F- 40

 NOTE
12 – SUBSEQUENT EVENTS

 In
accordance with ASC Topic 855, " Subsequent Events ", which establishes general standards of accounting for and disclosure
of events that occur after the balance sheet date but before this consolidated financial statement are issued, the
Company has evaluated all events or transactions that occurred after December 31, 2023, up through the date was the Company issued the
consolidated financial statements.

 On
January 23, 2024, the Company deposited $ 7,985 into the Trust Account in order to extend the amount of available time to complete a business
combination until February 23, 2024.

 On
February 23, 2024, the Company deposited $ 7,985 into the Trust Account in order to extend the amount of available time to complete a
business combination until March 23, 2024.

 On
February 9, 2024, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Company may borrow up to an aggregate
principal amount of $ 100,000 (the "Promissory Note"), respectively. The Promissory Note is non-interest bearing and payable
upon consummation of business combination.

 On
March 22, 2024, the Company deposited $ 7,985 into the Trust Account in order to extend the amount of available time to complete
a business combination until April 23, 2024.

 F- 41